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Movement disorders such as Parkinson’s disease (PD) will affect a rapidly
growing segment of the population as society continues to age. Without a known
cure, PD is causing tremendous financial and logistical challenges for patients and
society. The early diagnosis of PD and accurate assessment of PD severity stage
after diagnosis is crucial for prompt and proper treatment. However, currently
there is no objective test or biomarker that can clearly identify PD. The “gold
standard” of PD diagnosis is neuropathological assessment (performed during au-
topsy). A standard non-invasive PD test is mobility assessment. The current
diagnostic process requires a skilled medical professional and specialized equip-
ment (such as motion-capture camera arrays), and thus is expensive, non-scalable
and prone to human error.
With the advances in low-cost miniature inertial sensors (accelerometers and
gyroscopes) in the recent decade, systems based on inertial sensors have showed
great potential in motion analysis and monitoring. However, the accuracy of iner-
tial sensors-based movement measurement still needs improvement in order to be
used in clinical settings. Furthermore, there is no closed-loop system using inertial
sensors for mobility analysis as well as PD diagnosis, evaluation, and treatment.
In this thesis, we investigate inertial sensor-based mobility analysis algorithms and
systems for PD. We developed and validated two systems: a smartphone-based
mobile application (iRACE) and a wearable system using custom-built inertial
sensors (MANA).
iRACE uses a smartphone to assess motor performance and deliver customized
Rhythmic Auditory Cueing (RAC) to facilitate gait training, which is a well-
supported intervention for the treatment of gait impairments in PD. The smart-
phone’s built-in inertial sensors are used to assess step time and step length during
walking, and the touchscreen is used to assess motor timing during index finger
tapping. Novel machine learning-based gait analysis algorithms have been de-
v
veloped for iRACE, including heel strike detection, step length quantification,
and left-versus-right foot identification. The concurrent validity of iRACE was
assessed using a clinic-standard instrumented walking mat and a pair of force-
sensing resistor sensors. Results from 12 PD patients and 12 age-matched healthy
elderly reveal that iRACE has low error rates (< ±1.0%) across a set of four clin-
ically relevant outcome measures for motor performances with and without RAC,
indicating a potentially useful clinical tool.
MANA (Mobility ANAlytics) is a cost-effective, accurate, wearable and scal-
able system based on custom inertial sensors. We performed a clinical trial on
sixty subjects equally split into six severity groups (forty with various stages of
PD). Each subject was equipped with five sensors (two embedded in the shoes,
two on the wrists, and one on the waist) and was instructed to perform a walking
test and a motor control test. Comprehensive temporal and spatial gait analyses
were performed based on the sensor data. Novel stride length algorithms were
developed based on sensor fusion and kinematic constraints, which outperformed
existing methods. Furthermore, we were able to classify subjects into six severity
groups with 90% accuracy, and also estimate the UPDRS (Unified Parkinson’s
Disease Rating Scale) motor score. Our experiments showed that MANA is an
effective and promising platform for clinical mobility analysis, with a wide range
of potential applications in PD and beyond.
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1.1 Background and Motivation
The global population is ageing at an unprecedented rate. According to a United
Nations report in 2015 [152], the elderly population (aged 60 years or over) of the
world is projected to grow by 56% between 2015 and 2030, reaching 1.4 billion. By
2050, the elderly population will approach 2.1 billion, which is more than double
of its size in 2015. This population ageing trend is more prominent in Singapore,
which is expected to see a 97% growth in the next 15 years, with the percentage
of the elderly population increasing from 17.9% to 32.0%.
With this ageing population comes an increasing set of social and economic
challenges to manage the distribution of healthcare of age-associated chronic dis-
eases in such a large group of people. Diseases that overwhelmingly affect the
elderly such as stroke and neurodegenerative disorders (e.g., Alzheimer’s disease,
Parkinson’s disease) will be a heightened burden on society.
Parkinson’s disease (PD) is the second most common neurodegenerative disor-
der after Alzheimer’s disease, with more than 10 million people worldwide living
with PD [132]. PD is characterized by a decrease in the control of motor functions,
such as bradykinesia (slowness of movement), rest tremors, rigidity, and postural
and gait impairment. The incidence of PD increases with age, with a 2% ∼ 4%
1
risk for Parkinson’s among people over age 60 [132].
To date, PD has no known cure, and it imposes a considerable burden on
patients, healthcare systems and society. The combined direct and indirect cost of
PD, including treatment, social security payments and lost income from inability
to work, is estimated to be nearly $25 billion USD per year in the United States
alone [132]. According to a 2011 study of the economic burden of PD in Singapore,
the annual combined cost of PD was $11,345 SGD per patient, with a 38.5%
direct cost and a 61.5% indirect cost [161]. As productivity loss accounts for a
large share of the economic burden imposed by PD, early diagnosis and treatment
of PD with potential for returning patients to higher productivity are urgently
needed. Furthermore, PD does not only affect the elderly. An estimated 4% of
PD patients are diagnosed before the age of 50, and it is paramount for them to
receive PD diagnosis and treatment as early as possible in order to remain high
productivity for a longer time.
Despite the urgent need of early diagnosis of PD, currently there is no stan-
dard and objective diagnostic test or biomarker for PD. The current diagnosis
involves a skilled medical professional and requires specialized equipment, which
is expensive, non-scalable and prone to human error. The “gold standard” of PD
diagnosis is neuropathological assessment performed during autopsy. According
to a comparison of clinical diagnosis of PD and neuropathological assessment [15],
clinical diagnosis of PD in patients who have had the disease for more than five
years has relatively high accuracy (88%), this accuracy drops to 53% for patients
less than five years into the disease, and is only 26% for patients who have not yet
been treated for PD at all. Therefore, objective non-invasive methods of diagnosis
are greatly needed.
A common non-invasive PD test is mobility assessment, which aims to quantify
movement and give a clinical measure that reflects the degree of mobility impair-
ment. It is used in diagnosis and severity evaluation, which is fundamental for
medical treatment planning. Mobility assessment includes the quantification of
2
both the lower and upper motor performance. Specifically, for lower motor perfor-
mance, stride (and step) time and length are the most fundamental and important
measures.
However, there is no product in the current market that can perform PD
diagnosis and severity evaluation based on mobility assessment. There are several
products for basic mobility assessment without any diagnosis of PD, although
they have several significant shortcomings that render it impractical to develop
scalable PD assessment systems based on them. For example, the two main types
of commercial products for mobility assessment are motion-capture camera arrays
(e.g., Vicon [13], about 1 million USD for a gait laboratory setup) and pressure
sensitive walking mats (e.g., GaitRITE [7], about $75,000 USD per unit). However,
both of these products are prohibitively expensive for developing countries, and
are primarily limited to clinical usage as they require dedicated laboratory settings
and technical expertise.
In addition to the difficulty of conducting mobility assessment, there is still
a large gap between the mobility analytics and a clear diagnosis of PD, which
requires the involvement of an experienced neurologist or physician. However,
these medical specialists are a scarce resource in most developing countries. Rural
and community hospitals in such countries are ill equipped to make an accurate
diagnosis of PD or even perform a mobility assessment, forcing (often frail) PD
patients to travel a long distance to hospitals in large cities such as Shanghai or
Mumbai.
Based on the above analysis, there is a strong need for a cost-effective, scalable,
accurate and objective system for mobility assessment, and furthermore, for PD
diagnosis and severity evaluation.
3
1.2 Objective and Scope
Since there is currently no objective test or biomarker for PD diagnosis and sever-
ity evaluation, this thesis will focus on PD evaluation methods through mobility
assessment. Specifically, inertial sensors including accelerometers and gyroscopes
are used for motion tracking. As will be reviewed in Section 2.2, although a range
of inertial devices have been developed and investigated, there is still no product
or solution in the market that can perform PD diagnosis and severity evaluation
based on mobility assessment. Several major challenges need to be resolved:
• A wearable inertial device is required, which is small, light and inexpensive
such that it is portable and scalable. It is preferable for the device to be easy
to put on, unobstructive for walking and daily activities, and even discreet
(or stealthy) so that it is suitable for long time monitoring both at home
and in public.
• Accurate algorithms need to be developed and validated to calculate motion
parameters (e.g., step time and step length) based on inertial sensors, and
more importantly, to diagnose PD and evaluate the severity of PD.
• A closed-loop system for monitoring and rehabilitation is needed, which
can track the patient progress, provide assessment and feedback, facilitate
rehabilitation exercises (e.g., gait training), and connect the patients and
doctors for easy communication and treatment planning.
In this thesis, we aim to tackle these challenges, and develop an inertial sensor-
based system for PD assessment. We explored the use of different inertial devices,
including smartphones with onboard sensors, and standalone inertial sensor mod-
ules. Specifically, the objectives of this thesis include:
• Develop a smartphone-based application to assess motor performance and
facilitate gait training for PD.
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• Build customized wearable sensors with companion mobile and web appli-
cations for whole-body movement analysis.
• Design algorithms for mobility analysis and PD evaluation, and validate the
algorithms on PD patients in clinical trials.
1.3 Contributions
In this thesis, we investigate inertial sensor-based mobility analysis algorithms and
systems for PD. Two systems were developed and validated: a smartphone-based
mobile application (iRACE), and a holistic mobility analysis system based on
custom-built wearable inertial sensors (MANA). The contributions of this thesis
are as follows:
• Developed the iRACE mobile app, which uses the built-in inertial sensors to
assess walking (by attaching the iRACE smartphone to the waist), and uses
the touchscreen to assess motor timing during index finger tapping. iRACE
also delivers customized Rhythmic Auditory Cueing (RAC) to facilitate gait
training.
• Proposed novel machine learning-based gait analysis algorithms for iRACE,
including heel strike detection, step length quantification, and left-versus-
right foot identification. Validated the accuracy of iRACE against ground-
truth devices in a clinical trail with 12 PD patients and 12 age-matched
healthy elderly, and these two groups of subjects can be separated by iRACE-
derived outcome measures.
• Developed the MANA (Mobility ANAlytics) system, including customized
wearable sensors, and a companion mobile app and web service for data
collection and visualization. MANA uses five sensors for motion tracking,
with two embedded in the shoes, two on the wrists, and one on the waist.
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• Proposed accurate temporal-spatial gait analysis algorithms for MANA.
Novel stride length algorithms were developed based on sensor fusion and
kinematic constraints, which outperformed existing methods. Validated the
MANA system and algorithms in a clinical trial with 60 subjects equally
split into 6 severity groups (40 with various stages of PD), which is one of
largest studies of its type.
• Built machine learning models for MANA by combining data from hand and
foot sensors, which are able to classify subjects into 6 severity groups with
90% accuracy, outperforming other PD classifiers. This study represents the
most complete and most clinically relevant PD severity group classification
in the literature. A binary classifier is also used to split the subjects into
two severity groups (98%-100% accuracy). A regression model is trained to
predict the UPDRS (Unified Parkinson’s Disease Rating Scale) motor score
with a mean absolute error of 5 points.
1.4 Organization
The remaining content of the thesis is organized as follows:
Chapter 2 presents a comprehensive review of the related works on inertial
sensor-based mobility analysis for PD, including an overview of PD, a comparison
of various inertial sensors, a brief description of different algorithms for mobility
analysis, a list of example applications for PD, and a short mention of other
mobility analysis technologies besides inertial sensors.
Chapter 3 describes the iRACE mobile app. Analysis algorithms for walking
and tapping are presented in detail. The clinical study design and experimental
results are described. Four clinical outcome measures are computed, and the
analysis of variance (ANOVA) is performed for these outcome measures to compare
iRACE with the ground-truth devices.
Chapter 4 describes the MANA system. Firstly the system architecture and
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custom-built sensors are introduced. Next, detailed descriptions of the temporal
and spatial gait analysis algorithms are presented. Methods for PD severity classi-
fication and UPDRS motor score regression are also described. Lastly the clinical
trial and experimental results are presented.
Chapter 5 concludes the thesis, highlighting contributions of this thesis, and





2.1 Overview of Parkinson’s Disease (PD)
The section provides an introduction to PD, with descriptions about the symptoms
and diagnosis methods. Additionally, gait impairments and gait training methods
are presented in detail.
2.1.1 PD Symptoms and Diagnosis
Parkinson’s disease (PD) is a chronic, degenerative neurological disorder that
mainly affects the motor system [79]. It was first characterized extensively in
1817 by an English doctor, James Parkinson [91]. The motor symptoms of PD
are caused by the death of cells in the substantia nigra (a region of the midbrain),
although the cause of this cell death is still unknown. The substantia nigra cells
produce dopamine, a neurotransmitter responsible for transmitting signals within
the brain that allow for coordination of movement. Loss of dopamine makes pa-
tients less able to direct or control their movement, and thus PD is also categorized
as a movement disorder. An illustration of a PD patient is shown in Figure 2.1.
Four motor symptoms are considered cardinal in PD [79]:
• Tremor: trembling in hands, arms, legs, jaw, and face.
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Figure 2.1: Illustration of Parkinson’s disease by William Richard Gowers, first pub-
lished in A Manual of Diseases of the Nervous System (1886)1.
• Rigidity: stiffness of the limbs and trunk.
• Bradykinesia: slowness of movement.
• Postural instability: impaired balance and coordination.
PD motor symptoms typically begin on one side of the body, and eventually
affect both sides. As these symptoms become more pronounced, patients may
have difficulty walking, talking, or completing other simple tasks. In the ad-
vanced stages of the disease, other symptoms may also occur, such as dementia,
depression, anxiety, and sleep difficulties.
PD is a slow progressive disorder. The Unified Parkinson’s Disease Rating
Scale (UPDRS) is the most commonly used metric for PD severity assessment [62].
The UPDRS consists of six main parts, covering various aspects of PD symptoms
as well as complications of therapy. Part 3 of the UPDRS is the clinician-scored
monitored motor evaluation, which is frequently used by clinicians and researchers.
1https://en.wikipedia.org/wiki/Parkinson%27s_disease
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Part 5 of the UPDRS is the Hoehn and Yahr staging of PD severity [63]. The
Hoehn and Yahr scale defines five basic stages of progression:
Stage 1 Symptoms on one side of the body only.
Stage 2 Symptoms on both sides of the body. No impairment of balance.
Stage 3 Balance impairment. Mild to moderate disease. Physically independent.
Stage 4 Severe disability, but still able to walk or stand unassisted.
Stage 5 Wheelchair-bound or bedridden unless assisted.
The UPDRS is evaluated by clinical interview and observation, which is time
consuming and subject to human error. Thus, objective and accurate methods for
PD severity assessment are needed.
Despite two centuries of research, the root cause of PD remains unknown. Most
patients have idiopathic PD (having no specific known cause). Recent studies
have shown that a small proportion of cases can be attributed to known genetic
factors [95]. Other factors such as environmental toxins and pesticides have been
associated with the risk of developing PD, but no causal relationships have been
proven [64].
Currently, there is no objective test or biomarker that can clearly identify PD.
A physician will diagnose PD from the medical history and a neurological exami-
nation [79]. Brain scans are sometimes used to rule out disorders that could give
rise to similar symptoms. The “gold standard” of PD diagnosis is neuropathologi-
cal assessment (performed during autopsy). According to a comparison of clinical
diagnosis of PD and neuropathological assessment [15], clinical diagnosis of PD
in patients who have had the disease for more than five years has relatively high
accuracy (88%), this accuracy drops to 53% for patients less than five years into
the disease, and is only 26% for patients who have not yet been treated for PD at
all. Therefore, objective non-invasive methods of diagnosis are greatly needed.
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To date, there is no cure for PD. Medications, surgery, and multidisciplinary
management can provide relief from the symptoms. The main families of drugs
useful for treating motor symptoms are levodopa and dopamine agonists [129; 57].
However, in the long term, levodopa preparations can lead to motor complications
such as dyskinesias (involuntary movements) and fluctuations in the response to
medication [57]. When medications are not enough to control symptoms, surgery
and deep brain stimulation can be performed [37]. In addition, rehabilitation and
palliative care can be provided to improve quality of life.
A standard non-invasive PD test is mobility assessment, which aims to quan-
tify movement and provide a clinical measure that reflects the degree of mobility
impairment. It is used in diagnosis and medical treatment planning in the early
phases of the disease. In the latter phases, mobility assessment may also be fre-
quently necessary to monitor a patient’s progression. Mobility assessment includes
the quantification of both lower and upper motor performance. Specifically, for
upper motor performance, the basic tests include hand rotation, index finger tap-
ping, and so on. For lower motor performance, stride (and step) time and length
are the most fundamental and important measures. Additionally, gait variabil-
ity measures such as traditional statistical quantities (e.g. coefficient of varia-
tion) [35], detrended fluctuation analysis [42], and phase coordination index [135]
are extremely useful for clinical evaluation.
Experiments have shown that even PD patients on medication show a reduc-
tion in gait parameters such as cadence and stride length relative to age-matched
healthy controls [129; 109]. In addition, PD patients attempting to perform motor
tasks at a constant rate show larger variation than healthy controls performing
the same tasks. For example, a study showed that PD patients have a larger step
time variability (7%) than healthy controls (4%) [47]. Gait measurement in a
clinical setting is normally quantified using pressure sensitive walking mats [111],
heel-mounted force-sensing sensors (or footswitches) [73], or motion-capture cam-
eras [117]. All of these systems are costly, non-portable, often require either tech-
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nical or clinical expertise to use, and as a result do not scale easily. However,
Inertial Measurement Unit (IMU) based cyber-physical systems have shown great
utility in medicine, and are inexpensive, scalable, portable, and importantly can
be used outside of the hospital [41].
2.1.2 Parkinsonian Gait and Rhythmic Auditory Cueing
As a chronic movement disorder, PD causes various motor impairments as the
disease progresses. Gait impairment is a very common symptom, which is also
known as “Parkinsonian gait”. Parkinsonian gait is characterized by stooped pos-
ture, shuﬄing steps, flexed knees, narrow base, and reduced arm-swing [36], small
shuﬄing steps (festination) and a general slowness of movement (hypokinesia), or
even the total loss of movement (akinesia) in extreme cases [121]. Patients with
PD demonstrate reduced stride length and velocity during walking while cadence
and double support duration are increased. These influences on gait parameters
still remain even when the patients are tested during the “peak” effect of medi-
cation [109]. As a result, gait impairment can seriously affect the daily activities
and quality of life of the patients.
Freezing of gait (FOG) and falls are two common episodic phenomena in
Parkinsonian gait, and they occur more frequently in the advanced stages of the
disease [36]. Freezing of gait is when patients walking suddenly lose the ability to
lift their feet and become stuck in place for several seconds or even minutes de-
spite their efforts to initiate forward movement. Two of the most common forms of
FOG are “start hesitation” (when the patient wants to start walking) and “turn-
ing hesitation”. FOG and falls are usually closely intertwined, with FOG leading
to falls in many instances. Falls mainly result from sudden changes in posture, in
particular turning movements of the trunk, or attempting to perform more than
one activity during walking. The incidence of falls in PD is high: an estimated
two-thirds of patients fall at least once a year, and half experience multiple falls
per year [68]. Moreover, falls usually cause severe consequences such as injuries
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(e.g., fractures), hospitalization, and disability.
FOG and falls are both disabling symptoms, and they impose a serious chal-
lenge to PD patients. Furthermore, both symptoms often respond poorly and
even paradoxically to treatment with dopaminergic medication [36]. Therefore,
multidisciplinary management of these symptoms is needed.
To treat the motor symptoms, especially gait impairments, physical therapy
has been the subject of systematic reviews and “best practice” treatment recom-
mendations for therapy delivery [85]. Various rehabilitation programs have been
designed to control symptoms. Regular physical exercise has shown to be benefi-
cial to maintain and improve mobility, flexibility, strength, gait speed, and quality
of life [17; 65]. Task-specific gait training may also lead to long-term gait improve-
ment. For example, studies have utilized body weight support systems during gait
training on a treadmill, where subjects are suspended from an overhead harness
with straps around the pelvic girdle [113]. After a one-month training, improve-
ment in multiple gait parameters (e.g., walking speed) was found which also lasted
in the subsequent months.
A specific, evidence-based treatment recommendation is the use of rhythmic
sensory cueing ( [100; 141]). As the basal ganglia is dysfunctioning in PD and
stops acting as an internal cue for gait, various external sensory cues including
auditory and visual cues have been developed to bypass the cueing functions of
basal ganglia. Rhythmic auditory cueing (RAC; also called rhythmic auditory
stimulation) is the use of an auditory pacing stimulus (either a simple metronome,
or music with a steady beat) to which patients attempt to synchronize while
walking. The tempo of the auditory cue is usually set at or slightly above the
subject’s usual cadence. The visual cues are commonly transverse lines or rods
on the floor (floor markers). Such cues can improve stride length and velocity in
Parkinsonian gait by substituting kinaesthetic feedback with visual feedback for
regulating movement amplitude [98].
Figure 2.2 shows a digital metronome for RAC and a walking stick with a red
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a. b.
Figure 2.2: Auditory and visual cueing for gait training. (a.) A digital metronome
used to deliver rhythmic auditory cues2. (b.) A walking stick projecting a red laser
beam on the ground as a visual cue3.
laser beam for visual cueing. The function of RAC can also be implemented in an
app running on a smartphone that most people already have, which is convenient
and easy to adjust the auditory cues [163].
The beneficial effects of RAC on gait training have been noted for several
decades, such as increasing stride length, walking velocity and cadence, and ame-
liorating freezing of gait [80; 46; 24]. The time effects of RAC have also been
studied. Single-session RAC leads to improvements along multiple gait parame-
ters (e.g., velocity, stride length, and stepping rate [100]), and a handful of multi-
week interventions have found sustained improvements in gait parameters during a
post-intervention follow-up [45; 130]. Long-term training with RAC-based physical
therapy leads to sustained improvements in gait when walking without RAC [18].
Perhaps most importantly, RAC leads to a reduction in motor timing variabil-
ity (MTV), quantified as stride-to-stride timing fluctuations during walking (for
a detailed discussion, see [72]). PD patients have significantly higher MTV dur-
ing walking than healthy controls, even under normal medication regimens [101].




Figure 2.3: Illustration of the operation principles of accelerometers4 (left) and gyro-
scopes5 (right).
risk [71]. Therefore, reduced MTV by RAC means less falls (and thus less cost of
falls) in PD.
2.2 Inertial Sensors
This section reviews the inertial sensors (accelerometers and gyroscopes) used for
motion analysis. The sensors may be embedded in smartphones, or standalone
wearable devices.
2.2.1 Introduction
Inertial sensors including accelerometers and gyroscopes have been widely used
to track translational and rotational movements. Accelerometers measure the ac-
celeration, and gyroscopes measure the angular velocity. The common operation
principle of accelerometers is based on a mechanical sensing element which consists
of a proof mass attached to a mechanical suspension system with respect to a refer-
ence frame (Figure 2.3). Inertial force due to acceleration or gravity will cause the





in displacement of the proof mass can be measured electrically by the internal
circuitry and output as an electrical signal. Piezoresistive, piezoelectric and dif-
ferential capacitive accelerometers are the most common types [127]. For instance,
differential capacitive accelerometers measure the proof mass deflection through
the change in capacitance between the proof mass and sensing plates. Similarly,
gyroscopes use Coriolis effect to transform an angular velocity into a displacement
(cf. Figure 2.3). The Coriolis force acts perpendicular to the rotation axis and to
the velocity of the body in the rotating frame. The displacement induces a change
in capacitance between the mass and the housing, thus transforming the angular
rate into an electrical output.
In order to measure movements in three dimensions, triaxial inertial sensors
are commonly used nowadays. An Inertial Measurement Unit (IMU) usually con-
tains an accelerometer and a gyroscope, which are assembled together on the
same circuit board or even in a single chip. Recent advances in the construction
of microelectromechanical systems (MEMS) have made it possible to manufacture
small and light-weight inertial sensors with relatively low cost. For example, In-
venSense [9] MUP6050 (or MUP6000) IMU chips combines a 3-axis accelerometer
and a 3-axis gyroscope in a small 4×4×0.9mm package (shown in Figure 2.4),
thus providing 6 Degrees of Freedom (DOF). These miniature IMU chips have
been widely used in mobile devices, such as smartphones and wrist bands.
In many applications such as posture recognition or navigation, IMUs are
used in combination with other sensors, such as magnetometers or GPS (Global
Positioning System) receivers. A hybrid magnetometer and IMU device is often
referred as a MIMU or MARG (Magnetic, Angular Rate, and Gravity) sensor.
With the magnetometers measuring the direction of the magnetic field, MIMUs
can usually provide a good estimation of the sensor orientation [104]. IMU-based
navigation systems can be used together with GPS to improve accuracy [87], or
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7 Applications Information 
7.1 Pin Out and Signal Description 
Pin Number MPU- 6000 
MPU- 
6050 Pin Name Pin Description 
1 Y Y CLKIN Optional external reference clock input.  Connect to GND if unused. 
6 Y Y AUX_DA I2C master serial data, for connecting to external sensors 
7 Y Y AUX_CL I2C Master serial clock, for connecting to external sensors 
8 Y  /CS SPI chip select (0=SPI mode) 
8  Y VLOGIC Digital I/O supply voltage 
9 Y  AD0 / SDO I2C Slave Address LSB (AD0); SPI serial data output (SDO) 
9  Y AD0 I2C Slave Address LSB (AD0) 
10 Y Y REGOUT Regulator filter capacitor connection 
11 Y Y FSYNC Frame synchronization digital input. Connect to GND if unused. 
12 Y Y INT Interrupt digital output (totem pole or open-drain) 
13 Y Y VDD Power supply voltage and Digital I/O supply voltage 
18 Y Y GND Power supply ground 
19, 21 Y Y RESV Reserved. Do not connect. 
20 Y Y CPOUT Charge pump capacitor connection 
22 Y Y RESV Reserved. Do not connect. 
23 Y  SCL / SCLK I2C serial clock (SCL); SPI serial clock (SCLK) 
23  Y SCL I2C serial clock (SCL) 
24 Y  SDA / SDI I2C serial data (SDA); SPI serial data input (SDI) 
24  Y SDA I2C serial data (SDA) 
2, 3, 4, 5, 14, 
15, 16, 17 Y Y NC Not internally connected. May be used for PCB trace routing. 
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Figure 2.4: An InvenSense MUP6050 chip contains a 3-axis accelerometer and a 3-axis
gyroscope in a miniature package6.
For human motion tracking and mobility analysis, inertial sensors are usu-
ally used in two types of systems: standalone wearable sensor modules (cf. Sec-
tion 2.2.2) and smartphones with built-in sensors (cf. Section 2.2.3). Nowadays
many smartphones (including iPhones and various Android phones) and similar
mobile devices (e.g., iPod Touch) have rich onboard sensors such as accelerome-
ters, gyroscopes and even magnetometers. Furthermore, they are equipped with
powerful CPUs, large data storage, touch screens, Internet and usually Bluetooth
connections, enabling smartphones as a holistic and self-contained platform for
sensor data collection, processing and display.
In contrast, standalone wearable sensors (e.g., Fitbit [5]) need to assemble an
IMU, a microprocessor, a data storage module (e.g., EEPROM) and a battery in
a small circuit board. To transfer data, sensors also need to integrate a USB port
and/or a Radio Frequency (RF) or Bluetooth module for wireless transmission.
Standalone sensors generally have limited storage and computing power. As they
are smaller and lighter than smartphones, they are more flexible and comfortable
to wear on the body. Therefore, standalone sensors are used primarily as a data
acquisition endpoint (with preliminary onboard data processing), and the data is
relayed to smartphones or other devices for further analysis.
Compared to traditional devices in human gait assessment, such as foot-mounted
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force sensors [73], sensor-embedded walkways [111] and motion-capture cameras [117],
these inertial devices (smartphones and standalone sensors) have clear advantages
in portability, convenience, and cost efficiency. Therefore, inertial sensors have
been widely studied for gait analysis and for PD applications [61].
It is important to note that common MEMS inertial sensors are affected by
various sources of errors and require specific processing, which has been an active
research area [54; 123; 122]. These errors can be classified into two main categories:
deterministic (systematic) and stochastic errors. Calibration techniques can be
applied to remove the deterministic errors while the latter errors require proper
stochastic modeling methods. The main types of the sensor errors are summarized
as follows:
Noise Noise refers to random errors in the sensor measurement that can be intrin-
sic (produced by the sensor itself), or external (induced by environmental
interference). For example, magnetometer measurements may be affected by
its mounting circuit board as well as nearby electrical appliances and metal
objects.
Sensor bias A bias is composed of two parts, a bias offset (deterministic), and a
bias drift (stochastic). The bias offset is generated directly by the sensors and
can be evaluated through calibration processes. The bias drift is the error
accumulated over time, which is random and requires stochastic modeling.
Scale factor errors The ratio between the sensor’s signal output and the sen-
sor’s input to be measured is indicated as scale factor error. This error
is usually deterministic and can be removed with specific calibration tech-
niques.
Nonlinearity error This error describes the uncertainty in non-linear scaling
between the sensor input and output, which exists even after the scale factor
error is compensated. A detailed calibration for the full range of the sensor
measurement is needed to quantify and mitigate the nonlinearity error.
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Non-orthogonality error This error is produced by an imperfect manufacturing
or mounting of the sensors, usually due to non-orthogonality of the axes.
This type of error can be calibrated and modeled.
For low-profile inertial sensors, these error characteristics may vary dramat-
ically from one sensor to another, and thus a thorough calibration needs to be
conducted for each sensor in a laboratory environment. Furthermore, as environ-
mental factors such as temperature [54] usually affect the stochastic characteristics
of the sensors, a practical field calibration procedure is desired, or the sensor data
analysis algorithm needs to be adaptive to different environments.
As the sensor errors are almost inevitable, various sensor fusion algorithms
have been developed by combining multiple sensor measurements to achieve a
better estimation. These algorithms will be reviewed in Section 2.3.
For wearable sensors, the choice of sensor placement also requires careful con-
sideration. Sensor placement refers to the location where the sensor is placed,
and how the sensor is attached to that location. It has a great effect on sensor
wearability, which indicates the unobtrusive and convenient attachment. Sensor
wearability is an important factor for natural and long-term monitoring. Further-
more, sensor placement also affects the characteristics of the recorded sensor data,
and thus the data analysis algorithm and its accuracy. Wearable sensors can be
placed on different parts of a human body [48]. In many cases, it is necessary
to measure the whole-body movement, and the sensors are commonly placed on
the lower back or the waist. Waist is close to the center of mass of a whole hu-
man body, so that the sensor data recorded at this location can better represent
the major human motion. Sensors can be easily attached to or detached from a
belt around waist level. Therefore, waist-placement causes less constraint in body
movement and discomfort can be minimized as well. Accelerometers can also be
attached to wrists, thigh, or ankles [156]. Ankle-attached accelerometers can sig-
nificantly reflect gait-related features during locomotion or walking. Steps, travel
distance, velocity, and energy expenditure can be estimated by an ankle-worn
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accelerometer. Sensors have also been placed at the top of head for measuring
balance during walking. Another consideration for sensor placement is how to at-
tach sensors to the human body [156]. Wearable sensors can be directly attached
to the skin, or with some form of indirect attachment by using straps, pant belts
and wristbands, or other accessories. Sensors and wearable devices can also be
integrated into clothing. In principle, the inertial sensors should be securely fit-
ted and attached to the human body in order to prevent relative motion between
the sensors and the parts of the human body. Loose attachment or unsecured fit
causes vibration and displacement of the wearable systems, and this is liable to
produce extraneous signal artifacts and to degrade sensing accuracy.
2.2.2 Standalone Wearable Sensors
There are plenty of standalone devices based on inertial sensors that have been
applied or validated in research and applications. Many of these sensors are com-
mercially available, and new products are still emerging in the market. These
devices are all self-contained motion tracking systems (including sensors, micro-
processors, batteries, etc.), which are small and easily wearable. Some devices
also have companion software for sophisticated motion analysis. According to
their functionality, these devices can be classified into three main groups:
• Holistic motion analysis systems containing both sensors and analysis soft-
ware. For example, the APDM company provides the Opal sensors and
Mobility Lab software for motion tracking in various applications.
• Data acquisition devices, such as the Shimmer3 and Axivity WAX9 sensors.
They output raw sensor data but do no provide motion analysis algorithms.
• General fitness tracking products, which only output basic motion parame-
ters such as the step count and/or walking distance. A well-known example
is the Fitbit wearable devices.
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Accelerometer X X X X X X X X X
Gyroscope X X - X X X X - X
Magnetometer X - - - X X X - -
Data
transfer
Bluetooth - X - X - X X X -
Radio Frequency X X X - X - - - -
Local storage X X X - X X -
Custom
hardware
Configurable - X - - X X X - X
Programmable - - - - - - - - X
Raw
data
Data export X X - X X X X - X
Streaming API X - - - X X X - -
Gait
analysis
Step count X X X - - - - X -
Step length - - X - - - - - -
Stride length X X X - - - - - -
User
software
Oﬄine App X X X X X X - X -
Web portal - X - X - - - X -
Based on a thorough survey of the literature and market, 8 typical inertial
devices are selected and compared regarding a range of hardware and software
features, as shown in Table 2.1 and Figure 2.5. These devices include: APDM
Opal [1], Physilog [11], IDEEA [8], Kinesia [10], Xsens MTw [14], Shimmer3 [12],
Axivity WAX9 [2], and Fitbit [5]. (For the sake of completeness, an indepen-
dent IMU chip MPU6050 [9] is also listed in Table 2.1.) The main features for
comparison include:
• Sensors for data acquisition: accelerometer, gyroscope, and magnetometer.
• Data storage and transfer methods: (1) Bluetooth, including various Blue-
tooth versions, from 2.0 (Bluetooth Classic) to 4.0 (Bluetooth Low Energy;
BLE), or even higher. (2) Other Radio Frequency (RF) transceivers except
Bluetooth, including standard and proprietary techniques. (3) Large local
storage via a flash or microSD card, enabling long-time oﬄine data record-
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Figure 2.5: Example photos of the inertial devices for comparison (left to right):
APDM Opal, Physilog, IDEEA, Kinesia, Xsens MTw, Shimmer3, Axivity WAX9, and
Fitbit Zip.
ing. Generally the sensor data is transferred to other devices for further
processing, such as smartphones and laptops. Bluetooth is a standard pro-
tocol and is already supported by most mobile devices. Therefore it is more
convenient than other RF protocols for wireless sensor data transmission, as
the latter usually requires extra hardware components.
• Customizability of the hardware: (1) Configurable, such as changing the
sampling rate of the sensors via a provided API. (2) Programmable, that is,
uploading a custom program (e.g., a fall detection algorithm) to the proces-
sor of the device. These are important features for research and development
of new functions. However, most devices have no or very limited customiz-
ability.
• Availability of raw sensor data: (1) Export of raw data, either through an
open API or proprietary software. (2) API for real-time streaming of raw
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data, very useful for advanced applications.
• Gait analysis functions, such as computing step count, step length, and stride
length. These parameters can be immediately helpful to users and clinicians.
However, only a few devices provide this functionality, and their accuracy
varies. Besides, several devices by default only measures the stride length,
but not the step length, because it is not straightforward to compute step
length from two sensors attached to the feet.
• Software for users: (1) Oﬄine applications running locally on the desktop or
mobile devices, mainly for sensor data collection, processing and/or visual-
ization. (2) Online web portal and cloud service for storing user information
and history data. This feature can facilitate remote communication between
patients and doctors, as in the case of the Kinesia system.
The features and clinimetric properties of these devices are described next.
The APDM (Ambulatory Parkinson’s Disease Monitoring) company produces
the Opal sensor, which is a watch-sized device with a 9-DOF MIMU and a pro-
prietary RF protocol. The companion motion analysis software, Mobility Lab, can
compute outcomes such as postural sway (frequency, velocity, distance), lower limb
gait (cadence, stride velocity, stride length), postural transitions (step count, step
time), upper limb gait and trunk (trunk range of motion) measures. The software
has several modules, such as iTUG (instrumented Timed Up and Go test). The
iTUG test was shown to be sensitive to untreated PD and to potentially detect
progression of PD and response to symptomatic treatments [160].
Physilog (from the Gait Up company) is an ambulatory analysis system that
uses IMU to assess spatio-temporal parameters of gait, tremor, and physical ac-
tivity. It also supports Bluetooth transmission and web portals for users. Exper-
iments showed that Physilog is able to detect gait cycles and related gait events
with high accuracy [143].
IDEEA (Intelligent Device for Energy Expenditure and Activity) is a wearable
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ABSTRACT 
This paper examines an increasingly relevant topic in the 
multimedia community of wearable devices that record the 
physical activity of a user throughout a day.  While activity and 
other accelerometry-based data has been shown effective in 
various multimedia applications -- from context-aware music 
retrieval to approximating carbon footprint -- the most promising 
role of these target application for healthcare and personal fitness.  
Recently, several low-cost devices have become available to 
consumers.  In this paper, we perform an evaluation on the most 
popular devices available on the market (in particular Fitbit and 
Nike+) and report our findings in terms of accuracy, type of data 
provided, available APIs, and user experience. This information is 
useful for researchers considering incorporating these activity-
based data streams into their research and for getting a better idea 
of the reliability and accuracy for use in life-logging and other 
multimedia applications. 
Categories and Subject Descriptors 
H.3.0 [Information Storage and Retrieval]: General;  
K.8.2  [Personal Computing] Hardware; 
B.8.0  [Performance and Reliability] General;  
General Terms 
Measurement, Performance, Experimentation, Standardization 
Keywords 
Fitbit; Nike+ Fuelband; Fitness Applications; Social Media; 
Activity Monitoring; Quantified Self; Life Logging 
1. MOTIVATION AND INTRODUCTION 
Close to 70 years ago, Vannevar Bush published his seminal 
futuristic essay “As We May Think” [2] that envisioned a day 
when individuals would have access to a device that could store 
their entire collection of books, records, and communications in a 
manner that could be easily retrieved and examined. Bush 
postulated that this device, termed Memex (a combination of 
memory and index) would not only allow an individual to access 
their own “lifelog”, but also a collective information/knowledge 
pool which would thereby benefit all of mankind. 
Bush’s vision has had great influence on the development of many 
aspects of the World Wide Web as well as how personal 
collections of videos and images are shared and organized [4,7].  
Interestingly, however, Bush’s prediction did not envisage 
archiving an individual’s daily physical activity as part of one’s 
personal lifelog or for use as public sociality knowledge.  This 
may be due to the lack of importance associated to physical 
activity 70 years ago.  However, in modern times, it is well 
accepted that physical activity is crucial for both mental and 
physical well-being [15], and small wearable devices are making 
this possible to incorporate activity streams into our personal and 
collective “memory index”.  
Personal activity data has already been shown to be effective in 
various multimedia applications. Examples include context-aware 
music retrieval [14], as well estimating one’s carbon footprint [5].  
However, the most promising role for this data is in applications 
targeting health and fitness.  In particular, prior work has shown 
that wearable sensors can benefit individual patient health [1], 
individual personal fitness [16], and epidemiology studies to 
assess the large scale activity of populations [13].    
Early work examined data collected from specialized or research-
grade accelerometry-based devices [3,15].  Seeing the benefits of 
this technology, several companies have now produced wearable 
activity monitoring devices at price levels that are attractive to 
everyday consumers.   While various trade magazines periodically 
review these devices via anecdotal feedback, there has yet to be a 
systematic evaluation of these devices to examine their accuracy 
or suitability in terms of research and application development.  
This paper aims to provide this information by evaluating several 
devices including the two dominant market products, Fitbit and 
Nike Fuelband (see Figure 1).   The findings in this paper are 
useful for researchers interested in incorporating these devices 
into various multimedia and life-logging applications. We also 
outline related open problems in the multimedia systems area. 
Permission to make digital or hard copies of all or part of this work for 
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Figure 1: Devices evaluated in our study from left to right: 
iPhone Moves app, Fitbit, Nike+Sportsband and Fuelband, and 
conventional pedometers. 
 
Figure 2.6: Devices evaluated in a study [69]: iPhone Moves app, Fitbit, Nike+
Sportsband and Fuelband, and conventional pedometers.
system based on accelerometers for activity monitoring and gait analysis. It has a
Main Recorder, which wirelessly connects with limb sensors, and sends recorded
data to a computer via a USB cable. However, IDEEA has no API to export raw
sensor data.
Kinesia integrates an IMU in a ring that fits on a finger, and sends the IMU
data by wire to a wrist-mounted component, which transmits data to an iPad
via Bluetooth. A study showed the Kinesia system can ascertain tremor with
increased time resolution, which could help evaluate the efficacy of treatment and
improve patient management. Importantly, 45% of the subjects indicated they
would prefer not to wear the device in public [60].
Data acquisition devices including Xsens MTw, Shimmer3, and Axivity WAX9
sensors are similar. They all have a 9-DOF MIMU, and provide an API for raw
data streaming. The Xsens MTw sensor differs from the other two as it does
not support Bluetooth, and thus requires an extra dongle to be connected to
a computer for data transmission. These devices have been employed in gait
monitoring applications for PD, and analysis algorithms were developed based on
the collected raw data [88; 118].
Fitbit is a typical fitness tracking device, and has several models such as One,
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Zip, and Flex. It can calculate the steps, distance, and also calories burned.
In a recent study [69], popular motion tracking devices are evaluated, including
iPhone Moves app, Fitbit, Nike+ Sportsband and Fuelband, as shown in Fig-
ure 2.6. Results showed that significant variations exist among different devices
regarding the accuracy of step count and distance estimation. Specifically, Fitbit
devices achieved highest accuracy, whilst the iPhone app showed large errors in
step counts.
The above devices/systems are all very expensive, with a possible exception
of Fitbit (about 100 ∼ 300 USD). Usually a single sensor (e.g., APDM Opal,
Physilog, Xsens MTw, Shimmer3) costs 300 ∼ 1000 USD, and the corresponding
gait analysis software or data collection SDK costs 2000 ∼ 8000 USD. For example,
a package of 2 APDM Opal sensors and the Mobility Lab software costs about
9000 USD, which is not affordable for many individual patients.
2.2.3 Smartphone Built-in Sensors
With the rapid growth of mobile devices (e.g., smartphones) and the emergence
of mobile cloud computing technology [50], mobile devices are becoming a ubiqui-
tous computing platform in our daily life and healthcare. Compared to standalone
inertial sensors that usually have to relay the sensor data to smartphones or com-
puters, these mobile devices are simpler as they directly utilize the built-in inertial
sensors. Furthermore, smartphones and similar devices have more advanced fea-
tures as a platform, such as on-device data analysis and visualization.
Currently, mobile platforms Android and iOS are the most popular ones, taking
up approximately 99% of the market share [3]. Apple produces numerous iOS
devices, such as iPhones, iPod Touches, and iPads. Android smartphones have
a wide range of brands, such as Samsung, Sony, and Huawei. Nowadays, the
hardware of high-end smartphones (e.g., iPhone 7 and Samsung Galaxy S7) are
increasingly powerful in computing and storage (e.g., quad-core 2.34 GHz CPU, 4
GB memory, and 128 GB storage). Software development on mobile platforms is
26
Table 2.2: Smartphone-based gait investigations.
Reference Subject N Device Location Fs
[40] HC 1 iOS Left pocket 100
[92] HC 1 iOS Left ankle 100
[93] HC 1 iOS Left ankle 100
[94] HC 1 iOS Left ankle 100
[76] HC 1 Android Front waist 60
[157] HC 13 Android L3 100
[110] HC 49 Android L3 50
[126] HC 30 Android L3 33
[131] HC 49 Android L3 50
[155] HC/RA 20/39 Android L3 33
Notes: N is the number of healthy controls (HC) or patients with rheumatoid
arthritis (RA) tested. “L3” indicates device placed in the vicinity of the third
lumbar vertebrae on the lower back. Fs is the sampling frequency of the device’s
IMU in Hz.
also convenient, and mobile app distribution channels such Google Play and App
Store make app development and distribution a high possibility for companies and
researchers.
A number of recent studies have investigated the viability of smartphone’s
built-in IMU (accelerometer and/or gyroscope) to measure and quantify human
gait [40; 76; 94; 110; 126; 131; 155; 157], with key details summarized in Table 2.2.
A careful reading of this group of studies, however, reveals several concerns.
First, in some cases [40; 76; 94], only a single healthy subject’s data was ex-
amined, precluding the ability to infer whether the specific algorithms or analyses
that were used would generalize across individuals.
Second, in some cases [94; 155], no concurrent ground-truth gait analysis was
utilized, precluding any assessment of the sensitivity, specificity, and temporal
precision of smartphone-derived calculations. In other cases [110; 126; 157], larger
samples of healthy adults were studied, and a conventional waist-mounted tri-
axial accelerometer was employed as ground truth. Such a design, however, is
suboptimal, in that it would reveal only whether the smartphone’s accelerometer
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functions as well as a conventional accelerometer, rather than whether the smart-
phone actually (and accurately) captures the spatio-temporal dynamics of human
gait, as measured by “gold standard” devices: foot-mounted force-sensing resis-
tors [73], sensor-embedded walkways [111], ground reaction force plates [150], or
motion-capture cameras [117].
Third, some studies [94; 126; 155; 157] did not utilize traditional step-level
spatio-temporal analysis (i.e., heel strike detection and step time/length quantifi-
cation), which is standard in classic IMU-based gait analysis [165; 166]. Instead,
these studies used statistics which quantify properties of the raw accelerometer
waveform, such as its peak frequency after a fast Fourier transform, or the period
at which successive peaks appear in the waveform’s autocorrelation. Although
such statistics are mathematically valid, they lack clinical utility, as there are no
large-scale studies which provide normative or relative (e.g., PD patients versus
age-matched controls) values for these statistics, unlike traditional outcome mea-
sures (for reviews, see [74; 102]; cf. Section 3.5 below).
Finally—and most relevant to the current work—no previous study has eval-
uated the validity of smartphone-based gait analysis in PD patients.
2.3 Algorithms for Mobility Analysis
This section reviews the algorithms for inertial sensor-based human motion anal-
ysis, especially for the lower limb motion, i.e., gait analysis.
2.3.1 Overview
Inertial sensors can be used to track the movement of different body parts, such
as the limbs and trunk. Cardinal motor symptoms of PD include tremor, rigidity,
bradykinesia, and postural instability (cf. Section 2.1). Tremors may happen in
hands, arms, legs, and face. A study used Kinesia sensors worn on fingers to
monitor the tremors in hands and arms [60]. A tremor scoring algorithm was
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developed by extracting time- and frequency-domain features from the IMU raw
data, and then using a linear regression model to map these features to the UPDRS
tremor sub-score.
Most of these motor symptoms occur on lower limbs during walking, also known
as Parkinsonian gait. Therefore, gait analysis is the most important component of
mobility analysis for PD. Common measurements performed during gait analysis
include:
• Body posture and joint angles (ankle, knee, hip, etc.) [103].
• Temporal-spatial parameters of gait events (e.g., step time and step length).
• Abnormality detection, such as freezing of gait, and falls.
From these basic parameters, further information can be derived, such as:
• New gait parameters, e.g., step velocity (step length / step time), and ca-
dence (steps per minute).
• Statistics of gait events, e.g., mean and standard deviation of step time.
• Comparison of these parameters between two feet, e.g., left/right step time
ratio.
These outcome measures can provide high level information about gait stability
and symmetry, and thus reflect the degree of gait impairment.
Usually the first step of gait analysis involves segmenting each gait cycle from
the sensor data, and identifying each stage in a gait cycle. A typical gait cycle
is illustrated in Figure 2.7. Each foot has two alternating phases during walking,
stance and swing, which are separated by Heel-Strike (HS) and Toe-Off (TO)
events of the feet. The step time is the duration between two successive HS of
the two feet, while the stride time is between two successive HS of the same foot.
The transition from stance to swing involves the foot “peeling” from the floor,
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Figure 2.7: Illustration of a gait cycle. Gait phases (stance and swing) are separated
by Heel-Strike (HS) and Toe-Off (TO) events of the left (L) and right (R) feet.
the stance phase begins with the heel contacting the floor (the HS event) before
the foot flattens. The foot remains flattened until the transition to the swing
begins, and the cycle restarts. Therefore, identifying the HS and TO events is a
fundamental task in gait analysis.
Various algorithms have been developed for gait cycle analysis, which will be
detailed in Section 2.3.2. After each gait cycle is segmented, spatial gait param-
eters such as step length and stride length can be calculated. However, it is not
trivial to obtain accurate displacement estimation from the raw IMU data, due
to the inevitable errors and noises in the signal (cf. Section 2.2.1). A wide range
of methods have been investigated trying to solve this problem, as reviewed in
Section 2.3.3.
2.3.2 Gait Cycle Detection
To detect steps or strides from the IMU data, different algorithms have been de-
veloped. The minimum requirement of these algorithms is accurate step counting,
and a higher level requirement for many applications is accurate step segmen-
tation. Therefore two main types of algorithms can be identified: stance detec-
tion algorithms, and step cycle detection algorithms. Stance detection algorithms
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identify periods of data where a given foot is planted on the floor (i.e., the stance
phase). To this end, the sensor is mounted to the foot. Typically these algorithms
are appropriate for step counting but give poor segmentation output. Step cy-
cle detection algorithms detect cycles in the sensor data caused by the repetitive
motion of walking. This may involve searching for repeating data patterns or for
repeating events (e.g. HS and TO events). These algorithms are suitable for step
segmentation.
Typical stance detection algorithms are based on thresholds, which are usually
determined manually or empirically. The principle is that the sensor will be static
during the stance phase and the inertial sensors should report a corresponding lack
of activity that thresholding can easily identify. Most algorithms threshold on the
accelerometer magnitude [39], although angular velocity thresholds have also been
used [128] and combinations have been investigated [58]. In some cases applying
the threshold to the moving variance of the signal has been preferred to applying
it to the instantaneous magnitude [81]. A successful stance detection enables step
counting simply by assuming one stance period per stride per foot. Experiments
showed errors of just 0.1% and 0.2% based on thresholding accelerometer variance
and angular velocity, respectively [81]. It is worth noting that threshold-based
stance detection assumes at least one sensor on each foot, which is currently still
costly for a large deployment of shoe sensors.
Due to the complexity of the shoe movements (e.g., shoe deformation and
bounce) and the empirical nature of thresholds (cf. [86]), the start and end points
of a threshold-computed stance period do not represent the true HS or TO events.
Rather they represent an inconsistent subset of the full stance period. Therefore,
other techniques have been developed to identify specific events for data segmen-
tation, as well as to allow the sensors to gather data from elsewhere on the body.
These include:
Peak detection The heel strike is associated with sharp changes to the IMU
data. Standard peak detection algorithms can be used to highlight potential
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strikes. Note that each foot impact may generate multiple local peaks the
nearer to the foot the sensor is sited, due to the higher forces resulting in
sensor bounce [55]. This can significantly increase the algorithm complexity
in order to handle the local peaks properly.
Zero crossings This is a simpler way to use the cyclic property is to monitor the
acceleration value for zero crossings (essentially a form of thresholding) [66].
This is a popular choice for pedometers or activity monitors due to its sim-
plicity and computing efficiency.
Auto-correlation The cyclic nature of walking leads to strong periodicity in the
sensor data, regardless of the attachment site. The cycle can be extracted
by seeking maxima in the mean-adjusted autocorrelation of a sequence of
sensor data, such as the acceleration magnitude [159]. Whether the peaks
correspond to a step or a stride will depend on where the sensor is attached—
the nearer to a foot, the more asymmetric the response for each step. If a
sample sequence of data for a step or stride has previously been collected,
cross-correlation with this “template” data can also identify steps or strides
using the same process.
Spectral analysis This method involves computing the frequency spectrum of
the cyclic data and identifying strong peaks at typical stepping frequencies.
Windowed subsets of the data (with a width that includes at least two cycles)
are converted to the frequency domain and the dominant frequency taken
as the walking frequency [96].
As it is most common for humans to adopt a natural and relatively consistent
walking pace, these algorithms are usually robust for normal gait. However, for
abnormal gait in PD where the sensor data has irregular peaks and patterns, these
algorithms still need improvement in order to be accurate and generalizable to a
large population. Besides, the last two methods depend on identifying periodicity
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in the sensor signals. It is difficult for such algorithms to handle changes in walking
speed, to capture one-off steps or to reject false positives caused by any repetitive
movement within the expected frequencies.
2.3.3 Displacement Estimation
IMU-based displacement estimation is widely used many applications, such as gait
analysis, dead reckoning, and inertial navigation systems [39; 81]. The fundamen-
tal algorithms for displacement estimation in these applications are usually similar
or related. Algorithms for IMU-based displacement estimation can be generally
grouped into three categories:
Gait model These algorithms derive the displacement from the measured kine-
matic information and a predefined model of the gait. For example, two legs
can be modeled as the two sides of an isosceles triangle during walking, and
the step length can be estimated from the length of the legs (already known
or measured) and the angle between two legs (calculated from the IMU
data) [114]. Several studies used a double pendulum model for the swing
phase and an inverse double pendulum for the stance phase, where three
joints (hip and knees) and four segments (shank and thigh) are modeled [21;
143].
Abstraction model Instead of studying the specific walking biomechanics, these
algorithms use statistical and machine learning models (e.g., neural net-
works) to directly convert the IMU data to displacement [146; 163]. Either
raw IMU data or high level features (e.g., mean and standard deviation of
a segment of data) extracted from the raw data can be used as the input to
these models.
Direct integration The main idea is to measure walking acceleration through
inertial sensors, so that the velocity and displacement can be derived by
single and double integration of acceleration [29; 128; 99; 20].
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Usually the accuracy of algorithms based on gait models and abstraction mod-
els is limited because they rely on models which vary between people. Moreover,
the generalizability of these algorithms needs further validation as most existing
studies have a limited number of test subjects. In addition, the resultant training
or setup phase for these models can take a long time, rendering systems based on
these algorithms less convenient to use. Algorithms based on direct integration are
relatively accurate and simple. However, these algorithms need to handle noises
and drifts during integration properly.
In principle, integration-based algorithms consist of three main steps [29; 162]:
1. Orientation estimation. During movement, the sensor moves and rotates
with respect to the global frame of reference (with axes in the horizontal
and vertical planes). The sensor orientation in the global frame needs to
be determined first. In principle, rotation angle can be obtained from the
gyroscopic data (integration of angular rate). In addition, accelerometer
(or magnetometer) data is usually combined in a sensor fusion algorithm to
achieve better orientation estimation.
2. Sensor data projection. The sensor data (e.g., acceleration) is recorded
within the rotating sensor frame. Based on the sensor orientation, the ac-
celeration data is projected to the global frame. This can be achieved by
multiplying the acceleration data (as a vector) by a rotation matrix (deter-
mined by the orientation).
3. Double integration. After projection, gravity is removed from the accel-
eration, and double integration of acceleration gives the sensor displacement
in the global frame. For simplification, many algorithms only use accelera-
tion in the global horizontal axis for double integration, as the subjects are
assumed to be walking on a level ground, which is common and appropriate
for the majority of buildings [162].
In practice, the integration of angular rate and acceleration often results in
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accumulated errors in time (integration drift), mainly due to the inevitable mea-
surement errors within the sensor data. To counter drift it is necessary to regularly
close the integration loop by applying external constraints to the system. The most
common constraint is provided by Zero Velocity Updates (ZUPTs), with good re-
sults reported [58]. ZUPTs assert that the sensor is stationary during the stance
phase provided the sensor is attached to the foot. Therefore, the acceleration and
velocity during stance is reset to zero. The application of ZUPTs means that
open loop integrations only occur during the swing phase of the foot to which the
sensor is attached. For such short durations, drift accrual is limited and longer
tracking durations are thus feasible. For a reliable output, however, ZUPTs must
only be applied when the foot (and hence sensor) is completely static. Issues can
arise when the sensor is attached any higher than the ball of the foot. The peeling
motion associated with the transition from stance to swing means the heel rises
soon after the foot-down event and hence a sensor in the mid-foot will start ex-
periencing an acceleration as the foot levers up. These small accelerations occur
before the strict end of the stance phase and it is necessary to account for these
errors.
To mitigate the measurement errors, sensor fusion algorithms have been de-
veloped, which combine the information from different sensor measurements by
utilizing their overlapping and complimentary properties. In theory, more infor-
mation can be obtained from sensor fusion than an individual sensor, thus reducing
the ambiguities in the sensor measurement. These sensor fusion algorithms are
usually referred to as filters, such as complementary filters and Kalman filters.
Complementary filters provide a means to fuse multiple independent noisy
measurements of the same signal that have complementary spectral character-
istics [108; 106]. As a common example of sensor orientation estimation, the
gyroscope provides information about orientation via the integration of angular
rate, and the accelerometer provides orientation information from the direction
of gravity. The simplest method to combine these two sources of orientation es-
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timation is taking the average of them. However, considering the high frequency
information in the gyroscope-based estimation, and low frequency information in
the accelerometer-based estimation, a natural way (i.e., complementary filtering)
is to apply a high pass filter and a low pass filter to these two estimations respec-
tively, and then combine the filtered values. As a result, complementary filtering
can usually generate a better estimation.
Kalman filtering uses a series of measurements observed over time that contain
statistical noise and other inaccuracies, and estimates the unknown variables by
using Bayesian inference and estimating a joint probability distribution over the
variables for each timeframe. The Kalman filter works in a recursive two-step
process. In the prediction step, it produces estimates of the current state variables,
along with their uncertainties (i.e., covariances). Once the outcome of the next
measurement (necessarily corrupted with some amount of error, including random
noise) is observed, these estimates are updated using a weighted average, with more
weight being given to estimates with higher certainty. Since nonlinear process
and measurement models are generally required to describe the sensor dynamics,
nonlinear filtering methods such as the Extended Kalman Filter (EKF) are used.
The main idea of EKF is to linearize the estimation and observation equations (i.e.,
using a linear approximation) around the current solution and turn the nonlinear
filtering problem into a linear problem. EKF is commonly applied in inertial
navigation systems (INS), whereby the filter tracks the errors in the system state
rather than the system state directly. A 15-state model is commonly used (cf.
Figure 2.8): three states each for position, velocity and attitude errors plus six
states to model the accelerometer and gyroscope biases [58]. Finally the position
(i.e., displacement) can be extracted from the model. Magnetometers provide a
direct estimate of the sensor heading, which can be incorporated into the EKF
framework by applying them as absolute heading measurements, and is useful for
correcting the heading drift. However, the Earth’s magnetic field is relatively weak
at its surface and modern buildings filled with metal and conducting wires, leading
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Fig. 4. The standard INS solution involving a 15-state Extended Kalman Filter
wires, can overpower the natural signal, leading to local
‘disturbances’. Afzal et al. performed detailed experiments
indoors and concluded that different building materials have
significantly different effects on magnetometers, with heading
errors of up to 100◦ observed [49]. In their office environment,
Rai et al. report magnetic errors were contained to within 15◦
at 90% of their test locations, with a maximum deviation of
30◦ observed.
A common correction algorithm is to reject any readings
where the magnitude lies outside some tolerable range of the
expected value. Afzal et al. noted that this can be overzeal-
ous since vertically polarised magnetic fields will affect the
magnitude but not the horizontal heading [50]. To use this
knowledge, however, requires that the pose of the sensor in
the world frame of reference be known except for horizontal
heading so there are practicality issues.
Combining both gyroscope and magnetometer inputs has
yielded some success since the two sensors have comple-
mentary error characteristics—gyroscopes give poor long-term
orientation, while magnetometers are subject to short-term
orientation errors. Kim and Park exploited this by comparing
the angular velocities measured by the gyroscope with those
computed from successive magnetometer readings [12]. A
significant difference was taken to signify the presence of
a magnetic disturbance and the compass measurements were
discarded. Their results indicated an improvement but only
considered one environment that was not reported to suffer
from strong magnetic disturbances.
Magnetic disturbances can also be modelled within the EKF
framework of Figure 4 as per [27], [39]. By assuming a high
spatial frequency of disturbances, the EKF is able to estimate
the covariance in the heading measurement. However, Foxlin
noted that the large number of updates typically applied during
a stance phase can bias the result strongly, and so used only
a single magnetometer reading per step [27].
In summary, there are many proposals for techniques to
address magnetic disturbances to aid in heading determination.
However, more detailed testing in a wide variety of environ-
ments is needed before any firm conclusions can be drawn.
In the meantime, fusing gyroscope output with the compass
provides a heading estimation (or heading change estimation)
that is reasonably robust in most environments.
C. Results of INSs with ZUPTs
Ultimately, integration drifts limit the usefulness of pure
INS-based techniques for anything other than short-term in-
door tracking. ZUPT-based INSs typically exhibit return-to-
start errors6 of the order of a few metres in the literature. How-
ever, the testing usually involves contrived situations where
the user’s initial position is known and they are told to walk
along prescribed paths without stopping. Little consideration
has been given to more natural situations, where a user may
move to avoid obstacles, may sit and swing their legs, may
amble aimlessly, or may perform some unusual activity such
as jumping or skipping. The practicality of requiring a foot-
mounted sensor (for ZUPTs) also detracts from the solution.
Nonetheless, ZUPT-based INSs have been shown to give
good medium-term tracking accuracies when combined with
building maps (see Section VI).
V. STEP AND HEADING SYSTEMS (SHSS)
A drift-free INS provides a full 3D trajectory for a sensor.
Whilst useful, this level of detail is not necessary in most
tracking scenarios. Navigation in 2D in the horizontal plane
and using step vectors rather than complete limb trajectories
is sufficient. Step and Heading Systems (SHSs) output a series
6A return-to-start error is the error in predicted position after a user
performs a walk that brings them back to their start position, and is useful
when the true path of the walk is not available.
Figure 2.8: Block diagram of a 15-state Extended Kalman Filter used in an inertial
navigati system (INS) [70].
to local “disturbances”. Therefore extra preprocessing must be undertaken before
integrating the magnetometer readings [16].
The linearization in the EKF means that the original problem is transformed
into an approximated problem which is solved optimally, rather than approxi-
mating the solution to the correct problem. This can seriously affect the ac-
curacy of the obtained solution or lead to divergence of the system, especially
in cases that have highly nonlinear dynamics or measurement model , or that
lack a good a priori estimate of the state. Therefore, in systems of a highly
nonlinear nature and non-Gaussian noise sources, more refined nonlinear filter-
ing approaches such as Sigma-Point filters (Unscented Kalman filters), and par-
ticle filters (sequential Monte Carlo methods), which keep the nonlinear struc-
ture of the problem, resulting in potentially improved system performance [153;
43]. Howev r, the inherent weakness of these nonlinear filtering approaches is the
curse of dimensionality, where the computational complexity of the filter usually
grow exponentially with the dimension of the state vector being estimated [43].
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Therefore, even with today’s computational capacity, nonlinear filters can be un-
feasible for high-dimensional state vectors.
2.4 Inertial Sensor-based Applications for PD
Inertial sensors can be used to track the motor performance, and have a wide range
of potential applications for PD, such PD diagnosis and rehabilitation, which will
be reviewed in the following sections.
2.4.1 PD Diagnosis and Severity Evaluation
PD severity is commonly determined based on the clinical scale UPDRS, which
takes into account the presence and severity of PD symptoms to classify patients
into multiple stages of the disease, such as the Hoehn and Yahr staging (cf. Sec-
tion 2.1.1). It requires expertise and is subjective, and thus objective tools and
methods capable of performing this severity classification task are an important
research area. Inertial sensors have been used to evaluate tremor [82], dyskine-
sia [90] and bradykinesia [67] symptoms.
Well-established functional tests instrumented with IMUs such as the Timed
Get up and Go (TUG) and spontaneous sway have been the object of a number
of validation studies [160]. Results showed IMUs have potential to characterize
and objectively quantify functional deteriorations in patients with PD compared
to controls.
Researchers were also able to predict the UPDRS sub-score for bradykinesia ac-
curately, though they did not attempt to predict the full UPDRS motor score [19].
Detection and severity classification of individual symptoms such as tremor and
bradykinesia is also an active research area [133].
Research has shown that gait accelerometer data can be used to differentiate
between healthy subjects and PD patients [144], and also between young and el-
derly gait patterns [31]. Techniques using the built-in IMU in smartphones have
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been successful in distinguishing healthy controls and PD patients based on raw
accelerometer data [23]. IMUs have also shown potential for the differential diag-
nosis between idiopathic PD and drug-induced Parkinsonism [78], and idiopathic
PD and essential tremor [75]. Moreover, they may be useful for the detection of
individuals who are in a prodromal stage of PD [105].
In addition, PD severity has been automatically classified using support vector
machine classifiers into two categories (severe and not severe; as per the total
UPDRS motor score) [31; 140]. It is important to note that these studies have
relatively small datasets (less than twenty individuals and often without a healthy
control population) and they all classify PD patients into two severity groups
rather than clinically-based severity stages.
2.4.2 Activity Monitoring and Neurorehabilitation
Inertial sensors can be used for motor activity evaluation by assessing the quan-
tity and quality of movements. Quantitative data of physical activity monitoring
may provide ecologically valid information about disease progression, rehabilita-
tion success, and effects of medical and surgical interventions in patients with
PD [148]. Ambulatory systems have recently also been equipped with intelligent
algorithms and firmware to allow detection and analysis of transient and rare
events such as falls [27] and freezing episodes [119]. The detection of falls and
freezing of gait (FOG) is of particular importance for a reliable assessment of
patient’s independence and confidence in the daily environment. Furthermore,
helping functions can be integrated into the system. For example, a call for help
may be initiated automatically in certain situations such as a fall is detected.
Inertial sensors can also be integrated in neurorehabilitation, for example, gait
training based on Rhythmic Auditory Cueing (cf. Section 2.1.2). It was shown
for postural control that biofeedback training is able to improve disease-associated
deficits in PD patients [124]. In this study [52], the training device was a wearable
accelerometer measuring patients’ movements and coding them in real time into
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Figure 2.9: Illustration of the Vicon cameras and the markers on the body7.
an acoustic feedback provided through a headset. In the direction of providing
assistive devices, ambulatory systems may soon be tuned as wearable assistants
for patients with PD. For example, it is well imaginable that a worn IMU de-
tects FOG and helps the affected individual to overcome the event by cueing with
rhythmic auditory signals [25].
2.5 Other Mobility Analysis Technologies
There are various mobility analysis technologies besides inertial sensors, which
generally fall into two main groups: computer vision and pressure sensors, as
described in the following sections.
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2.5.1 Computer Vision
Computer vision-based mobility analysis usually uses an array of motion-capture
cameras to capture the body skeleton in motion, including arms, legs and so on,
and then analyze the temporal-spatial motion parameters [117]. The Vicon Motion
System [13] has been an industry standard for optical marker-based motion cap-
ture for decades, and has been successfully employed in a variety of applications,
including in special effects, biometrics, etc. The system uses an array of (e.g., six)
cameras to recover the 3D position of reflective markers placed on various points
of the body and thereby estimate the articulated pose of the body in 3D space
with very high accuracy [149; 83]. However, the use of markers (or color labels) on
the body is intrusive and inconvenient, and requires expensive specialized hard-
ware and time-consuming preparation of the subject. For example, it costs almost
one million USD to establish a complete gait laboratory based on computer vision
(including the hardware, software, laboratory setup, and personal training).
Researchers have also been investigating in marker-less motion capture systems
using conventional cameras without special apparel or other equipments. For
example, an algorithm based on annealed particle filtering was proposed to capture
articulated body motion using conventional cameras [49]. This algorithm was
shown to be capable of recovering full articulated body motion in 3D efficiently.
Microsoft Kinect cameras are commonly used in marker-less tracking systems
which provide both a color and depth image. There are some studies which use
these images to extract motion parameters. For example, a Kinect camera was
used in a study [53] to track the center of mass of a person. Another study [138] fo-
cuses on the effects of playing Kinect Adventures on the postural control of patients
with Parkinson’s disease. These studies use relatively expensive and specialized
cameras to track human motion, which require simple environments to avoid noise




Figure 2.10: Illustration of the pressure sensors attached to the foot8 (left) and the
GaitRITE walking mat9 (right).
ing systems is that their accuracy is affected by complicated movements. This is
not ideal for tracking PD patients with abnormal gait patterns.
2.5.2 Pressure Sensors
Pressure sensors are transducers that convert mechanical force input (e.g., the force
between the foot and ground) into an electrical output signal. There are many
types of sensors measuring force, which can be grouped into three main categories:
(1) Strain gauge load cells, (2) Piezoelectric crystal, and (3) Measurement through
pressure. The force sensors can be made in different forms (size, shape, etc.) for
different scenarios, such as a small sensor plate attached to the heel to detect the
heel strike time, or an array of force sensors embedded in a mat to measure the





The force-sensing resistor (FSR) is a typical force sensor (e.g., Interlink Elec-
tronics FSR® 400 series10). FSR sensors are widely used in gait analysis [73],
including gait analysis in PD (for reviews, see [71; 72]). The FSR sensor can be
attached to the heel pad of each foot to record the moment of each heel strike
(Figure 2.10). When a heel strikes the ground, the pressure placed on the FSR
changes the sensor readings, and that changing timestamp can be used as the
“ground truth” heel strike time.
The foot-mounted FSR alone cannot measure the displacement of the foot, such
as step length. To overcome that limit, a sensor mat can be used. The GaitRITE
electronic walkway [7] is a 61 cm× 610 cm roll-up mat embedded with force sensors
arranged with 1.27-cm spacing (Figure 2.10). GaitRITE computes various spatio-
temporal gait parameters for each walk across the mat, such as cadence, step time
and step length [111]. Its accuracy has been validated by concurrent analyses
using insole footswitch sensors [32] and motion-capture cameras [154]. GaitRITE
has been the primary data collection device in numerous gait investigations in
the elderly, including PD patients (e.g.,[45; 102]). GaitRITE does not require
the subject to wear any special sensors on the body. However, pressure sensors
including GaitRITE can only assess gait parameters related to ground contact,
and they are unable to detect foot movement above the mat (e.g., foot angle) and








A review of published prevalence studies projects that the number of individuals
over the age of 50 with Parkinson’s disease (PD) living in 15 of the world’s most
populous nations will double between 2005 (roughly 4.4 million) and 2030 (roughly
9.0 million) [51]. Although administration of carbidopa/levodopa remains the
“gold-standard” treatment for motor impairments in PD [129], gait parameters
such as cadence, stride length, and velocity remain significantly reduced in PD
patients relative to age-matched healthy controls, even when patients are tested
during the “peak” effect of medication [109]. Together, these concerns motivate
the search for additional strategies or therapies to help maintain motor functions
in PD patients.
The use of physical therapy for the treatment of gait impairments in PD (e.g.,
bradykinesia, freezing, falling) has been the subject of systematic reviews and
“best practice” treatment recommendations for therapy delivery [85]. A specific,
evidence-based treatment recommendation was the use of rhythmic sensory cueing
(RSC)—in particular, rhythmic auditory cueing (RAC) (for reviews, see [100;
45
141]). RAC is the use of an auditory pacing stimulus (either a simple metronome,
or music with a steady beat) to which patients attempt to synchronize while
walking. As reviewed in Section 2.1.2, RAC on gait has been found to lead to
improvements along multiple gait parameters, such as velocity, stride length, and
motor timing variability.
Although the efficacy of RAC for PD (i.e., statistically significant improve-
ments in gait parameters) is well supported (e.g., [45; 100; 141]), RAC has not been
widely adopted due to the lack of affordable and convenient clinimetric tools that
would enable a medical professional (e.g., neurologist, physical therapist) to accu-
rately assess a patient’s motor performance in the short term, which could provide
insight into whether that patient would respond to RAC in the longer term [44;
130].
With the rapid growth of mobile devices (e.g., smartphones) and the emergence
of mobile cloud computing technology [50], mobile devices are becoming a ubiqui-
tous computing platform in our daily life and healthcare. Compared to traditional
devices in human gait assessment, such as foot-mounted force sensors [73], sensor-
embedded walkways [111] and motion-capture cameras [117], mobile devices have
clear advantages in portability, convenience, cost efficiency, and comprehensiveness
of platform features (e.g., on-device data collection, analysis and visualization).
Here, we describe such a tool to facilitate and “scale up” RAC interventions:
an iOS-based Rhythmic Auditory Cueing Evaluation (iRACE) mobile applica-
tion (“app”). iRACE operates on an iPhone or iPod touch, and connects to a
cloud-based website. iRACE records activities during walking (via the on-board
accelerometer and gyroscope) and index finger tapping (via the touchscreen). Mo-
tor production is assessed both with and without RAC, and the auditory cues can
be highly customized by each user. The recorded walking and tapping data is an-
alyzed to obtain the basic motor parameters (step time/length, tapping intervals,
etc.), as well as a set of four clinically relevant outcome measures. These results





Figure 3.1: iRACE app screenshots. (a.) Home screen. (b.) Settings for evaluation
parameters and playlists. (c.) RAC bimanual tapping. (d.) Rapid tapping. (e.)
Tapping analysis and visualization.
We have developed novel machine learning-based algorithms for iRACE gait
analysis, including heel strike detection, step length quantification, and left-vs.-
right foot identification. These algorithms were validated against ground truth
measures obtained from a clinic-standard instrumented walking mat and force-
sensing resistor sensors. Results from 12 PD patients and 12 age-matched healthy
elderly (HE) revealed that iRACE had less than±1.0% error rates (averaged across
subjects) across four outcome measures, indicating a potentially useful clinical
tool.
Using iRACE, medical professionals can easily assess whether RAC is effective
to an individual patient, and if so, use iRACE to deliver long-term RAC-based
therapy and monitor the patient’s performance over time, benefiting the patient
physically, mentally, and financially.
The rest of this chapter is structured as follows. Section 3.2 describes the
iRACE system. The clinical validity study design of iRACE is outlined in Sec-
tion 3.3. iRACE-based gait analysis, clinical outcome measures, and tapping
analysis are detailed in Sections 3.4, 3.5 and 3.6, respectively. Experiment ac-
curacy results and analysis of variance (ANOVA) of the outcome measures are




iRACE consists of three main components: an iOS-based mobile device such as an
iPhone or iPod touch (the “iRACE device”), a mobile application (the “iRACE
app”), and a back-end cloud computing service (the “iRACE website”). An iPhone
or iPod touch is equipped with an inertial measurement unit (IMU) comprising a
microelectromechanical tri-axial linear accelerometer and Coriolis vibratory gyro-
scope, each with a maximum nominal sampling frequency of 100 Hz. The device’s
capacitive touchscreen has a maximum refresh rate of 60 Hz. The IMU data
and touchscreen tap events are recorded during walking and tapping, respectively,
which are then uploaded to the iRACE website.
3.2.1 iRACE App
3.2.1.1 Overview
iRACE administers three widely used tests of motor performance of both walking
and finger tapping movements: (1) self-paced bilateral performance, (2) synchronization–
continuation bilateral performance, and (3) rapid unilateral and bilateral perfor-
mance. Launching iRACE (Figure 3.1a) provides the option to conduct a Walking
Evaluation (using tests 1–2) or a Tapping Evaluation (using tests 1–3).
iRACE has a number of flexible settings (Figure 3.1b), including the number of
iterations of each test and the desired playlist of RAC stimuli. The playlist can be
pre-defined and fixed across subjects, or dynamically generated such that its range
of tempos can automatically “bracket” each subject’s self-paced walking/tapping
tempo.
iRACE guides the user through all tests in succession. In a self-paced test,
no RAC is provided; the subject will walk or tap at a rate deemed most com-
fortable. In a synchronization–continuation test, the RAC stimulus is delivered
during the first part of the test (synchronization), during which the subject at-
tempts to walk or tap with the stimulus beat. After a pre-specified number of
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events (steps or taps), the stimulus fades to silence over a few seconds, whereupon
the subject attempts to continue the same pattern of movement at the same rate
(continuation).
3.2.1.2 Walking and Tapping Evaluations
Quantitative evaluations of self-paced [101] and RAC-based synchronization (for
reviews, see [100; 141]) walking are widely reported in the PD literature. During an
iRACE Walking Evaluation, the iRACE device is secured to the ventral surface of
the lower trunk (at the navel) using an elastic sleeve and waist band (Figure 3.2a).
Although several previous studies have positioned the accelerometer on the dorsal
surface of the body (e.g., over the third lumbar vertebrae; cf. Table 1), securing
the device at the navel enables the user to more easily interact with the iRACE
device (with an eye towards eventual home-based use). Both self-paced walking
and synchronization–continuation walking tests are performed in this manner.
Index finger tapping is a widely used motor timing assessment in PD, both
as a “fast-as-possible” test [62] and as a synchronization–continuation test [151].
To our knowledge, there exist no smartphone-implemented evaluations of finger
tapping in either healthy controls or patients with movement disorders. During all
tapping tests (self-paced, synchronization-continuation, and rapid; cf. Figure 3.1c–
d), the iRACE device is positioned on a desk or table such that the subject’s arms
and wrists are comfortably supported, permitting smooth index finger movements.
iRACE can process and visualize the tapping data in-app immediately after a test
(Figure 3.1e). (In-app gait analysis will be implemented in a future version of
iRACE.)
3.2.2 iRACE Website
A cloud-based service has been established to facilitate iRACE data management
and visualization. Each iRACE user can create an account to login the iRACE
app and website. The website has the following main features: (1) To build user
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profiles and manage user roles and relationships (patients, therapists, etc.); (2) To
receive and analyze data files uploaded from iRACE app; (3) To visualize walking
and tapping analysis results in tables and graphs; (4) To review evaluation history
and track user progress over time.
3.3 Clinical Study Design
This section describes the novel fusing of clinic-standard ground truth measures
with iRACE, and the testing protocol into which they were incorporated.
3.3.1 Ground Truth Gait Measures
As noted in Section 2.2.3, no previous investigation has validated smartphone-
based gait analysis using ground truth data that directly samples heel strikes
in the temporal and/or spatial dimensions. In our study, we utilized both: a
GaitRITE electronic walkway [7], and a force-sensing resistor assembly [6] and
telemetry unit (DataLOG [4]).
GaitRITE is a 61 cm × 610 cm roll-up mat embedded with pressure sen-
sors arranged with 1.27-cm spacing, with a maximum sampling frequency of 240
Hz. GaitRITE computes various spatio-temporal gait parameters for each walk
across the mat, such as cadence, step time and step length. Its accuracy has been
validated by concurrent analyses using insole footswitch sensors [32] and motion-
capture cameras [154]. GaitRITE has been the primary data collection device
in numerous gait investigations in the elderly, including PD patients (e.g., [45;
102]).
In the present study, a force-sensing resistor (FSR) sensor was attached to the
heel pad of each foot to record the moment of each heel strike. Both FSR sensors
were wired to a telemetry unit (DataLOG) and sampled at 1000 Hz as binary
values (0 if the pressure on FSR exceeds a certain threshold, and 1 otherwise).










Figure 3.2: Clinical study settings. (a.) iRACE device and DataLOG secured to a
belt on patient’s lower trunk. (b.) Straight line walking segment on GaitRITE. (c.)
Illustration of the walking path.
reviews, see [71; 72]). When a heel strikes the ground, the pressure placed on
the FSR toggles its reading from 1 to 0; that toggling timestamp was used as
the “ground truth” heel strike time. DataLOG also received an analog audio
signal directly from the iRACE app, which was used to synchronize iRACE and
DataLOG clocks (detailed in Section 3.4.2).
As DataLOG has a higher sampling frequency (i.e., with millisecond-level tem-
poral resolution) than GaitRITE, FSR and DataLOG recorded heel strike times-
tamps were used as the ground truth to validate the temporal precision of iRACE
(cf. Section 3.4.3), and GaitRITE was used to evaluate the step length algorithm
of iRACE (cf. Section 3.4.5).
3.3.2 Subjects and Testing Protocol
All subjects were recruited through the Singapore General Hospital clinics. A tele-
phone questionnaire was first administered to screen out potential subjects who (1)
are not within the age range of 40 to 85; (2) have any problems with their hearing;
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(3) are not able to walk independently without an aid; (4) have joint problems or
other neurological, musculoskeletal or medical problems that can affect walking;
(5) have sustained a fall within the past year that continues to affect their walking
pattern; (6) have had surgery to implant a device (e.g., deep brain stimulation
or pacemaker). Subjects who satisfied all six criteria were invited to participate
in the study. Upon arrival at the testing location, four clinical assessments were
administered to PD subjects, beginning 30 to 90 minutes after standard medica-
tion intake: the complete Unified Parkinson’s Disease Rating Scale (UPDRS), the
modified Hoehn & Yahr stage assessment, the Mini Mental State Exam [56], and
the Freezing of Gait Questionnaire [59]. Of these assessments, only the MMSE
was administered to HE subjects. All subjects had a MMSE > 24, indicating an
absence of cognitive impairment.
Our initial target sample size for this study was 15 PD patients and 15 age-
matched healthy elderly (HE) subjects. However, several issues during data col-
lection resulted in incomplete data sets from one or more RAC conditions for 3
PD patients and 3 HE subjects, due to: (1) an insufficiently tight connection be-
tween iRACE and the chest (i.e., a tighter elastic band was required than was
available at the time); (2) data lost from iRACE during file transfer; (3) poor
quality contact between the footswitch sensor and the heel, yielding irregular heel
strike timing data; or (4) insufficient data (particularly in GaitRITE, which yields
the fewest events per trial) due to patient fatigue. Because a complete set of data
across all experimental conditions is required for ANOVA (i.e., no missing values
are permitted), two options were available: (1) imputation of missing values or (2)
casewise deletion of any subject with a missing condition. Because any form of
data imputation would introduce its own new set of assumptions (e.g., as reviewed
in [77]), we chose the second option for the sake of parsimony and clarity.
Thus, a final sample of 12 PD patients (5 female) and 12 HE subjects (4 female)
were analyzed in this study. Table 3.1 presents key demographics and scores on
standard clinical ratings scales for each subject. A two-sample t-test revealed that
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Table 2. Demographics of the PD and HE samples, and clinical characteristics PD sample. 185 
 186 
 HE sample PD sample 
 Age (yrs) Gender 
MMSSE 








UPDRS III  
(0 to 56) 
H & Y 
(1 to 5) 
FOGQ  
(0 to 24) 
 63.4 M 30 58.8 M 30 7 20 4 22 
 51.0 M 30 72.1 M 30 3 33 2.5 10 
 68.5 M 29 77.5 M 28 8 16 3 6 
 66.1 F 29 63.4 F 24 14 24 2.5 5 
 67.6 M 30 65.5 F 29 6 28 2.5 2 
 64.9 M 30 81.0 M 30 2 37 2.5 1 
 59.1 M 29 61.8 F 30 2 36 2 0 
 60.5 F 26 63.5 M 28 4 14 1.5 2 
 65.8 F 29 63.2 M 29 8 8 3 8 
 79.9 M 29 49.8 M 30 5 38 2.5 9 
 52.0 M 30 60.6 F 30 4 21 2.5 1 
 58.2 F 30 62.3 F 28 3 22 3 10 
[Mean] 63.08 — 29.25 64.96 — 28.83 5.50 24.75 2.63 6.33 
[SD] 7.79 — 1.14 8.41 — 1.75 3.42 9.76 0.61 6.17 
 187 
“UPDRS III” is the Unified Parkinson’s Disease Rating Scale [72] section III (lower score indicates greater motor impairment);  188 
“H & Y” is the modified Hoehn & Yahr stage assessment [73] (higher score indicates more advanced PD stage); “MMSE” is the Mini 189 
Mental State Exam [74] (lower score indicates greater cognitive impairment); and “FOGQ” is the Freezing of Gait Questionnaire [75] 190 
(higher score indicates increased freezing severity).  191 
“UPDRS III” is the Unified Parkinson’s Disease Rating Scale section III (lower score
indicates greater motor impairment); “H & Y” is the modified Hoehn & Yahr stage
assessment (highe co dica es more advanced PD stage); “MMSE” is the Mini
Mental State Exam (lower score indicates greater cognitive impairment); and “FOGQ”
is the Freezing of Gait Questionnaire (higher score indicates increased freezing
severity).
the PD and HE samples did not differ in age (p = .577) or MMSE score (p =
.496).
All testing procedures were approved by the institutional review board (IRB)
at Singapore General Hospital. The iRACE “belt” and FSR sensors (Figure 3.2a)
were attached as described above (cf. Section 3.2.1.2 and 3.3.1). The experimenter
then demonstrated the target walking path (Figure 3.2c), including a 3-meter
acceleration/deceleration phase to allow for steady-state walking while on the
GaitRITE mat.
Each subject then completed four or more walking trials (i.e., enough to record
at least 40 steps on GaitRITE) in each of three sequential RAC conditions: (1) self-
paced (no RAC), (2) RAC with metronome tempo set to 100% of mean self-paced
cadence, (3) RAC with metronome tempo set to 110% of mean self-paced cadence;
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Figure 3. (a) Interpolation and resampling of acceleration wav f rm. (b) Annotated waveform points compared with DataLOG HS
timestamps. (c) Mean delay (d) std delay
Figure 5. tapping results
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Figure 3. (a) Interpolation and resampling of acceleration waveform. (b) Annotated waveform points compared with DataLOG HS
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Figure 5. tapping results
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Figure 3.3: (a.) Int rpolation an resampling of iRACE acceleration data. (b.) Anno-
tation of heel strike points (HS peak and HS trough) in the A–P waveform.
these two tempos are common in RAC [141]. (The mean self-paced cadence was
computed using GaitRITE, as the data was collected before the algorithms detailed
in Section 3.4 were developed.)
The iRACE Tapping Evaluation (cf. Section 3.2.1.2) was conducted after the
completion of the Walking Evaluation.
3.4 Walking Analysis
This section describes the processing pipeline used to transform the raw IMU
data recorded by iRACE into temporal and spatial gait parameters (step time,
step length, etc.).
3.4.1 Preprocessing
During a Walking Evaluation, the iRACE device was oriented with its screen fac-
ing forward and its “home” button facing up. iRACE simultaneously records 6
channels of IMU data in the iOS device xyz coordinate system: tri-axial acceler-
ation (ax, ay and az) and tri-axial rotation rate (ωx, ωy and ωz). For simplicity,
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from the subject’s perspective, we define anterior–posterior (A–P) acceleration as
aAP = −ax (positive values for anterior acceleration), up–down (U–D) accelera-
tion as aUD = −ay (positive values for upward acceleration), and left–right (L–R)
acceleration as aLR = az (positive values for leftward acceleration). Similarly, we
define the rotation rate around the A–P axis (i.e., roll) as ωAP = −ωx, around
the U–D axis (i.e., yaw) as ωUD = −ωy, and around the L–R axis (i.e., pitch) as
ωLR = −ωz.
Four preprocessing steps were applied: (1) IMU waveform interpolation; (2)
straight-line walking identification; (3) device tilt compensation; and (4) low-pass
filtering.
First, since the time interval between successive IMU samples varies stochasti-
cally, raw IMU data is usually interpolated and resampled at a fixed frequency [76;
110; 126]. In the present study, all IMU data was cubic-spline interpolated and
resampled at 1000 Hz, which as a result could refine the peak and trough locations
(i.e., improve temporal resolution) in the IMU waveforms (e.g., Figure 3.3a).
Second, an algorithm was implemented to isolate straight-line walking seg-
ments from turn segments (cf. Figure 3.2c), stationary segments, or other non-
walking segments (e.g., freezing). This was achieved by analyzing the acceleration
amplitude of aAP (to identify actual walking) and rotation rate ωUD (to identify
turning). For simplicity, only straight-line segments will be analyzed further.
Third, because the iRACE device usually pitches (around the L–R axis) as the
subject walks (thus affecting IMU waveforms and the accuracy of subsequent heel
strike detection), the A–P and U–D waveforms were adjusted (using a trigono-
metric algorithm) according to the estimated device tilt angle (based on rotation
rate ωLR and average gravity in A–P and U–D axes; derived from [115]).
Fourth, all IMU data was low-pass filtered with a 4th-order zero-lag Butter-
worth filter with a cut-off frequency of 20 Hz, as suggested by [165; 166].
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3.4.2 iRACE and Ground Truth Synchronization
Since the internal clocks in the iOS device and DataLOG are independent and
not synchronized, a novel synchronization method was developed via an acous-
tic signal. Specifically, iRACE generated a 2-second square-wave audio (using
the iOS Audio Units API). iRACE toggled the volume of this audio repeatedly
(approximately every 30 ms) between silence and normal volume, and saved the
toggling timestamps (in iRACE’s clock). DataLOG recorded this audio (at 2
kHz), which was then analyzed to locate these volume toggling timestamps (in
DataLOG’s clock), i.e., the rising and falling edges of the audio volume contour.
The temporal offset between the two clocks was found by linearly regressing the
DataLOG timestamps onto the iRACE timestamps; the y-axis intercept was the
“best fitting” offset in the least-squares sense, with sub-millisecond level accuracy.
GaitRITE records the session start time to the millisecond level, so that the
steps measured by GaitRITE can be correctly matched to those measured by
DataLOG and iRACE.
3.4.3 Waveform Annotation and Timing Analysis
Previous accelerometry-based gait analysis methods have used waveform peaks
(i.e., local maxima) in the A–P channel [110; 166] and/or U–D channel [112] as
analogues of physical heel strike (HS) events (for a review, see [84]). However, the
above papers were primarily focused on gait analysis in healthy individuals, and
have not been extended to gait analysis in PD patients. Even a brief glance at the
waveform excerpt from a PD patient in Figure 3.3b reveals that the widely used
convention of “an A–P peak preceding a zero-crossing” as a HS analogue [158; 165;
166] is problematic, as multiple zero-crossings may be present between successive
ground truth HS events (i.e., as recorded by DataLOG and FSR sensors).
To find out which accelerometry waveform event was the most temporally
stable analogue of a true HS event, a more systematic approach was taken in the
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Figure 3.4: Group mean (left panel) and standard deviation (SD; right panel) of the
temporal error (tε) between HS timestamps and annotated waveform peaks (tε,P ) and
troughs (tε,T ).
present study. For each ground truth HS timestamp (tHS), the timestamps of a
peak (tP ) and its subsequent trough (tT , i.e., local minimum) that were most likely
to correspond to tHS were manually annotated on the A–P and U–D accelerometry
waveforms. In general, tP (or tT ) was closest to tHS among all peaks (or troughs),
but exceptions existed due to irregular waveform fluctuations (i.e., irregular gait).
For convenience, manually annotated peaks and troughs will be referred to as “HS
peaks” and “HS troughs”, respectively (cf. Figure 3.3b).
After annotation, the signed temporal errors (tε) of four waveform event times-
tamps (i.e., tP,AP , tP,UD, tT,AP , tT,UD) relative to the corresponding tHS were cal-
culated for each tHS, and the mean (Mtε) and standard deviation (SDtε) of tε were
computed for each subject. Figure 3.4 present the group-level mean and standard
deviation (as error bars) of Mtε and SDtε across all subjects, respectively. Logi-
cally, temporal variability (i.e., SDtε) rather than temporal delay (i.e., Mtε) is the
more critical statistic, as a physical delay is inherent between a HS event and the
corresponding waveform peak/trough recorded in a waist-mounted accelerometer.
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A 2 (Channel : A–P or U–D) × 2 (Event : SD of tε,P or tε,T ) repeated-measures
analysis of variance (ANOVA) was performed, revealing a significant effect for
Channel (F1,9 = 26.86, p = .0006; i.e., A–P had lower SDs than U–D), Event
(F1,9 = 32.16, p = .0003; i.e., HS troughs had lower SDs than HS peaks), and
their interaction (F1,9 = 15.96, p = .003). Because A–P troughs (tT,AP ) had the
smallest group-level mean and variance of SDtε (cf. Figure 3.4), they may be
considered the most temporally stable analogue of HS events.
3.4.4 Heel Strike Detection
As highlighted in Figure 3.3b, conventional rule-based algorithms using hand-
crafted rules or hard-coded thresholds (e.g., a simple zero-crossing rule to identify
HS analogues) may be imprecise in PD patients, due to individual differences in
disease staging, bradykinesia, freezing, and so forth.
To address this limitation, a machine learning-based HS detection algorithm
was proposed, which formulates HS detection as a binary classification problem:
whether a given accelerometry A–P trough was a HS analogue (i.e., a HS trough)
or not. (A–P troughs are the most temporally stable waveform events relative to
true HS events; cf. Section 3.4.3.)
Firstly, two sets of features were extracted for each A–P trough: (1) Features
from the A–P trough (including the trough amplitude, the difference in time or
amplitude between a trough and its adjacent peaks, etc.); and (2) Features from
all accelerometer and gyroscope waveforms. The average step time (Ts; i.e., the
duration of a step) was previously derived from the A–P waveform autocorrela-
tion [157]. A segment (about 0.2×Ts) centered on the trough timepoint was se-
lected in each waveform, and features (mean, standard deviation, etc.) from these
segments were extracted and concatenated. These two sets of features together
formed a feature vector, denoted as fi for the i-th trough.
Next, a set of features based on a trough sequence (i.e., combinations of ad-
jacent troughs) was constructed for the i-th trough, including fi − fi−1, fi − fi+1,
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fi + 0.5fi−1 − 0.5fi+1, etc. After that, a set of the most statistically significant
features are selected among all the extracted features using the rankfeatures1
function in MATLAB (with a two-sample t-test used as the class separability
criteria).
A two-layer neural network classifier [33] then took the selected features as
input. The ground truth of whether each trough was a HS trough was derived
from the waveform annotation. Different numbers of selected features and units in
the hidden layer of the classifier were iterated and tested; the optimal parameter
combination was obtained, which yielded the highest classification accuracy based
on 10-fold cross-validation (for more details about parameter selection, see [33]).
In the present study, 100 selected features and 20 units in the hidden layer were
used.
For each trough, a number (continuously valued from 0 to 1) was output by
the classifier, indicating the probability of that trough being a HS trough. This
number was then thresholded at 0.5, giving an initial prediction of the identify
of a HS trough or a non-HS trough. Next, this initial prediction was refined, as
follows. Based on the previously derived average step time (Ts), a pair of rules was
applied: (1) If any two adjacent HS troughs were separated by less than 0.7×Ts,
the one with the lower probability was adjusted to a non-HS trough; (2) If no HS
trough existed in the window [0.7×Ts, 1.3×Ts] before or after the timestamp of a
given HS trough, the trough with highest probability in that window was selected
as a HS trough.
3.4.5 Step Length Calculation
After HS detection, the spatial displacement (i.e., step length) between successive
HS troughs was calculated. Algorithms for IMU-based step length calculation can
be generally grouped into two categories: double integration of acceleration [38;
162], and machine learning-based regression methods [146]. For trunk-mounted
1 http://www.mathworks.com/help/bioinfo/ref/rankfeatures.html
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smartphones, the main difficulties of the double integration method lie in the in-
tegration drift over time and the estimation of initial velocity at the beginning of
a step (i.e., the HS trough time), since the trunk velocity at that time is typically
non-zero. For example, in the present PD patients’ data, if the initial velocity
were set to zero (as assumed in [38]), the resultant step length based on double
integration usually drifted to a negative value.
To overcome these difficulties, a hybrid machine learning algorithm was pro-
posed, which took the double integration results together with other low-level
waveform features as the input, and uses neural network regression [33] to calculate
step length. Specifically, for each step, features were extracted from segments of
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2;
e.g., [40]) including single and double integration, time duration, standard devia-
tion, and so on. These segments include the exact step segment (between succes-
sive HS troughs) and its shifted versions (by half a step duration before or after
it). Similar features were also extracted from tri-axial gyroscope waveforms. Next,
Principal Component Analysis [33] was used to select the most significant features,
which were then input to a two-layer neural network regression model [33]. Model
parameters were trained using 10-fold cross-validation.
3.4.6 Left-versus-Right Foot Identification
Left versus right foot identification is important for clinical gait measures, but
presents some challenges when the measurement device is attached centrally at the
trunk. Some studies use L–R acceleration to distinguish left and right foot, based
on the sign of L–R acceleration, or the sign of its single or double integration [38;
165; 166]. These methods assume that the direction of trunk displacement is
different for different feet. However, the validity of these assumptions has not
been tested using smartphones, or in PD patients. We tested these methods in
our PD patient data, and confirmed that they worked for a majority of patients,
but some failure cases still existed due to weak and irregular L–R acceleration.
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At the same time, we observed that the gyroscope data (especially rotation rate
around U–D axis) usually also showed different patterns for different feet, which
relates to the different rotation directions of the trunk.
To fully utilize all accelerometer and gyroscope data, a machine learning-based
method was proposed for left-versus-right foot classification. For each step between
successive HS troughs, two sets of features were extracted. First, step-based fea-
tures (single/double integration, maximum, minimum, etc.) from segments of all
accelerometer and gyroscope waveforms. The durations of these segments include
the exact step duration (between successive HS troughs) and its shifted versions
(by half a step duration before or after it). These features are denoted as a vector fi
for the i-th step. Second, features from a step sequence, including fi−fi−1, fi−fi+1,
fi−0.5fi−1−0.5fi+1, etc. The ground truth of left-vs.-right foot was obtained from
DataLOG left and right foot sensors. As in the HS detection method (cf. Sec-
tion 3.4.4), feature selection was performed, and the neural network classifier was
evaluated using 10-fold cross-validation.
3.5 Clinical Outcome Measures
iRACE calculates four clinically relevant outcome measures that quantify specific
statistical properties of an event series (ES) {e1, e2, . . . , eN} of N successive
finger tap or heel strike timestamps (in elapsed seconds, relative to an arbitrary
“0” timepoint) or N successive heel strike displacements (in meters, relative to an
arbitrary starting position). An inter-event series (IES) refers to the first-order
difference (i.e., intervals) of an event series, with N−1 elements. An example heel
strike series is shown in Figure 3.5.
3.5.1 Outlier Flagging and ∆ES Creation
Outliers in an ES come in two forms: false positives (i.e., a “double tap” of the
same button during bimanual tapping, or a “double trough” in an A–P accelera-
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tion waveform; cf. Figure 3.3b), or false negatives (i.e., “missing” events due to
inadequate heel strike pressure or touchscreen contact, or by a priori exclusion of
turns during a walk; cf. Section 3.4.1).
For all walking and tapping trials other than Rapid Tapping, a simple “suc-
cessive percentage change” (SSPC) transformation was used to flag outliers in the





SSPC will have N − 2 elements relative to the original ES.
A single threshold percentage value (P ) was then set; here, P = 75. For any
SSPC,i ≥ P , the associated ES element ei+2 was flagged as an outlier. Additionally,
any repeated event on the same side of the body (i.e., the second of two successive
left or successive right taps or heel strikes) was flagged as an outlier. The first-
order difference of a series of ≥ 6 consecutive ES elements without an outlier flag
will be labeled a “∆ES” (cf. Figure 3.5b). For rapid tapping trials, a simpler
logic was applied: an outlier was identified as any IESi+1 which followed IESi
by less than 50 ms. This threshold was established to eliminate moments of
near-synchronous tapping that are more likely to occur during alternate bimanual
tapping, particularly at fast rates.
Subsequently, ∆ES across all trials within the same RAC condition are con-
catenated (as in [101]), so as to provide more stable outcome measures. For exam-
ple, if the self-paced condition contains four trials that each yielded a ∆ES of 10
∆-values, those ∆-values were concatenated into a single set of 40 ∆-values prior
to outcome measure calculation. Concatenated ∆ES with more than 50 elements
were truncated at 50. Importantly, the number of elements in the final ∆ES for
a given subject and RAC condition will always be identical for iRACE and the
heel contact–based device (i.e., ground-truth); thus, any differences in outcome
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Figure 3.5: Example heel strike series. (a.) A hypothetical heel strike series in which a
missing event is present. (b). The outlier-free event series is then subjected to a first-
order difference transformation (∆ES), from which outcome measures are computed.
Furthermore, for each trial, step time events which occurred before the first step
recorded on GaitRITE or after the last step recorded by GaitRITE were excluded
prior to outcome measure calculation. The average number of events per subject
per RAC condition was 36 (SD = 10).
3.5.2 Outcome Measures
Two statistics were calculated from a concatenated ∆ES. First, the mean of a
∆ES (∆M) is straightforward, and can be taken for either a timestamp ∆ES
(∆M,T ) or a displacement ∆ES (∆M,D). Two transformations yield the commonly
reported statistics of cadence (= 60/∆M,T , in steps-per-minute) and velocity (=
∆M,D/∆M,T , in meters-per-second). Second, the coefficient of variation of a ∆ES






where std(·) is the sample standard deviation.
Two other statistics were derived from a transformation of an outlier-free ES
proposed by [136] to quantify motor timing during walking. For each string of N
(N ≥ 3) right (eR) and N left (eL) events without an outlier flag, {eR,1, eL,1, eR,2,
eL,2, . . . , eR,N , eL,N}, two relative phase series were defined using the right (ΦR)
or left (ΦL) foot as the “reference” foot (the following formulas assume the first
R event precedes the first L event):
ΦR,i = 360
eL,i − eR,i
eR,i+1 − eR,i , ΦL,i = 360
eR,i+1 − eL,i
eL,i+1 − eL,i . (3.3)
For example, a ΦR,i = 180 indicates that the left event eL,i precisely bisects the
time (or displacement) between successive right events eR,i and eR,i+1.
The mean absolute percentage deviation from 180 (ΦM) indicates the presence



















The nature of the Φ transform means that ΦCV reflects local (i.e., event-to-
event) variability relative to the mean, while ∆CV reflects global variability relative
to the mean.
For parsimony, the maximum of ΦM,R and ΦM,L (referred to simply as ΦM),
and the maximum of ΦCV,R and ΦCV,L (referred to as ΦCV ) will be retained for
a given test. Thus, any reduction in the magnitude of ∆CV , ΦM , or ΦCV would
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Figure 3.6: Tapping simulation. (a.) and (b.) 60-Hz downsampled inter-event interval
(IES) series with a mean of 0.25 s and 1.0 s. (c.–f.) Outcome measures.
caused by the positive facilitation of RAC (relative to without RAC).
3.6 Tapping Analysis
Two limitations that occur when recording iOS touchscreen events have the po-
tential to affect the outcome measures of iRACE tapping. First, this touchscreen
has a relatively slow maximum sampling frequency (60 Hz) compared to the iOS
IMU (100 Hz). Second, the touchscreen datastream is effectively binary (0 = no
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contact; 1 = contact) rather than continuously valued like the IMU, precluding it
from interpolation (and the resulting refinement of temporal resolution; cf. Fig-
ure 3.3a). Together, these limitations suggest that iRACE estimates of inter-tap
interval variability (i.e., ∆CV and ΦCV ) may be inflated.
For example, as an IES becomes faster (i.e., with a smaller ∆M) or more
temporally stable (i.e., a smaller ∆CV , ΦM , or ΦCV ), the impact of 60-Hz sampling
error becomes more prominent; the potential error in each timestamp is a larger
proportion of the underlying period. This is highlighted in Figure 3.6a, which
visualizes an inter-tap interval series with a true ∆M = 0.25 s and ∆CV = 2.0%
(blue trace). However, after downsampling this series at 60 Hz (by advancing each
timestamp in the original series forward to the next possible 60-Hz sample point,
yielding the red trace), the observed ∆M is accurate (= 0.25 s) but the observed
∆CV is inflated (= 3.8%). By contrast, in Figure 3.6b, a series with a true ∆M =
1.0 s and ∆CV = 8.0% has both an accurate observed ∆M (= 1.0 s) and ∆CV (=
8.1%) after downsampling.
To systematically quantify the error induced by 60-Hz sampling on the four
temporal outcome measures (∆M , ∆CV , ΦM , and ΦCV ), the following simulation
was conducted. A random “pull” of 30 values (which forms an IES) was drawn
from the normal distribution (µ = 0, σ = 1), and shifted to have a mean of M
(where M = 0.125 to 1.0 in ten geometric steps). The corresponding ES series
was generated by taking the cumulative sum of the IES. Next, the value of ∆CV ,
ΦM , or ΦCV was rescaled (over separate manipulations) to have a value of exactly
P% (where P = 2.0, 4.0, or 8.0). The rescaled ES was then downsampled to 60
Hz. Finally, the four outcome measures were calculated from the downsampled
timestamps. In total 10 (M) × 3 (P ) × 2000 iterations were performed.
The simulation results are presented in Figure 3.6c–f, plotting the error induced
by 60-Hz sampling (y-axis) at different values of M (x-axis) and P (different
colors) for each outcome measure (separate panels). The median (heavy line) and
central 95% (lighter lines) of all iterations are shown for each P value. Several
66
conclusions can be made. First, ∆M is accurately captured at all levels of P ;
this finding is perhaps expected, as even with a fast M (e.g., Figure 3.6a), the
numerous underestimated and overestimated elements (relative to the simulated
ground truth) tend to cancel each other out. Second, as predicted, the accuracy
of all outcome measures increases (i.e., the y-axis width between each pair of 95%
lines decreases) as M increases. Most importantly, for the range of “plausible”
walking and tapping rates (i.e., ∆M ≥ 0.5 s, or 120 events-per-minute or slower),
outcome measures differ from ground truth by less than ±1.0%.
3.7 Experiment Results
This section presents the concurrent validation results, including the accuracy
of iRACE-quantified gait parameters, outcome measures, and measures of RAC
facilitation.
3.7.1 Gait Measurement Accuracy
A heel strike dataset of 7,677 HS events was combined across all Walking Evalu-
ations of all 24 subjects.
Each HS event has both a ground truth HS timestamp from the DataLOG
FSR sensor, and a manually annotated HS trough in iRACE A–P waveform. A
total of 30,479 A–P troughs (including 7,677 HS peaks and 22,802 non-HS peaks)
were identified. Based on 10-fold cross-validation, our HS detection algorithm (cf.
Section 3.4.4) achieved 100% precision and recall. If the binary output was directly
obtained from the classifier using a decision boundary of 0.5 (i.e., no further rule-
based refinement was applied), the precision and recall were 99.98% and 98.74%,
respectively (F1 score = 99.35%).
On the same HS dataset, our left-vs.-right foot identification algorithm (cf.
Section 3.4.6) also achieved 100% accuracy.
A step length dataset of 3,372 steps was combined across all walks of all sub-
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jects with ground truth step lengths collected from GaitRITE. The root mean
square error (RMSE) of our step length calculation algorithm was 3.57 cm based
on 10-fold cross-validation, or 6.08% when expressed as a CV value (i.e., RMSE
divided by mean step length).
3.7.2 Outcome Measure Accuracy
A repeated-measures Bland–Altman analysis [34] is presented for Step Time (Fig-
ure 3.7) and Step Length (Figure 3.8). As used here, a Bland–Altman analysis
summarizes the accuracy of an experimental device (iRACE) against a control
device (ground truth device; DataLOG or GaitRITE). Outcome measures from
individual trials (blue points) are averaged to create a single value per subject
(red points). The key statistics in a Bland–Altman plot are the y-axis mean
(dashed red line) and 2×SD error bars (solid red lines), which indicate the ex-
pected mismatch between the two devices at the population level (with the error
term adjusted for multiple trials per subject, per [34]). Similar to the tapping
simulation (cf. Figure 3.6c), ∆M was very accurately estimated for both Step
Time (Figure 3.7a) and Step Length (Figure 3.8a). Although the amount of y-
axis error in iRACE-quantified variability measures (∆CV , ΦM , ΦCV ) was greater
than that of ∆M , this error was less than ±1.0% in most subjects (i.e., averaged
across individual walks). This indicates that iRACE would be able to distinguish
parkinsonian gait from normal gait based on their percentage-based variability
measures, which can differ by as much as 5% for stride time variability [47] and
2.5% for stride length variability [22].
3.8 ANOVA of Outcome Measures
In seeking to validate a novel measurement device against a standard measurement
device, an analysis of the magnitude of measurement error is critical. Just as
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Figure 3.7: Bland–Altman step time analysis.














































































Figure 3.8: Bland–Altman step length analysis.
emerges; that is, the magnitude of measurement error relative to the magnitude
of the target experimental effects; for example, inter-group (PD vs. HE) and
inter-task (self-paced vs. metronome-cued) effects.
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3.8.1 Analysis Design
Three sources of variance are important to consider in the present experimental
design: inter-device variance (e.g., differences in outcome measure values between
the “standard” measurement device and the “novel” measurement device); inter-
group variance (e.g., differences in outcome measures between PD and HE, or
differences between “On” and “Off” medication states); and inter-task variance
(e.g., differences in outcome measures associated with task presence or task diffi-
culty). The context in which inter-device error emerges is important to capture,
and the method used to quantify it is an important consideration. For example,
although the Limits of Agreement on a Bland–Altman plot can quantify vari-
ance due to inter-device differences, they give no insight into expected sources of
variance: differences between groups (e.g., PD vs. HE), medication states (“On”
versus “Off”), treatment conditions (e.g., treatment present versus treatment ab-
sent), task difficulty levels (e.g., single- versus dual-task), and so on. Likewise,
although intraclass correlation coefficients are used to quantify inter-rater reli-
ability or test-retest reliability, they are statistically inappropriate for assessing
inter-device agreement [36]. Devices—unlike raters or test occasions—have a fixed
rather than a random assignment [72].
If on some measurement scale, for example, it were found that PD and HE
differed by 10 points on average, or treatment-present versus treatment-absent
conditions differed by 5 points on average, then an observed inter-device measure-
ment error of ±1 point may be deemed “acceptable” by a clinician—particularly
if the novel measurement device offered other advantages over the standard mea-
surement device (e.g., portability, convenience, cost, etc.).
In the present study, device-related measurement error associated with iRACE
versus heel contact-based gait measurement was assessed in the context of two well-
studied experimental effects: differences in outcome measures between PD and HE
and differences in outcome measures between self-paced versus metronome-cued
walking conditions. Analysis of variance (ANOVA) was used to assess inter-group,
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inter-condition, and inter-device differences simultaneously. By partitioning the
variance observed in the data into an underlying set of underlying sources, ANOVA
thus enables a comparison of the amount of “undesirable” variance due to device-
related measurement error (here, between iRACE versus heel contact-based de-
vices) relative to the amount of “desirable” variance due to inter-group effects
(here, Parkinson’s versus healthy) and inter-condition effects (here, self-paced
walking versus walking with RAC). (Inter-group and inter-condition variance are
“desirable” in that the greater the difference in scores between groups or between
conditions, the greater the discriminative ability of a given test instrument.)
For each outcome measure (step time and step length ∆M ; step time and
step length ∆CV ), three ANOVAs were performed using Statistica. Each of these
analyses represents a potentially “self-sufficient” experimental question, and thus
a distinct ANOVA design:
1. A Group (2 levels: PD and HE) × RAC (3 levels: self-paced, 100%, and
110%) × Device (2 levels: either iRACE and Biometrics footswitch sensors
for step time outcome measures, or iRACE and GaitRITE sensor walkway
for step length outcome measures).
2. A Group × Device ANOVA during self-paced walking to determine whether
differences between PD and HE were significantly different when measured
by iRACE versus the novel versus the standard device.
3. An RAC × Device ANOVA for PD patient group in isolation.
4. An RAC × Device ANOVA for HE subject group in isolation.
For each ANOVA component (main effect or interaction), eta-squared (η2) effect
sizes were computed [97]. η2 quantifies the proportion of total variance (from 0
to 1) that is captured by a particular ANOVA component. By convention, an
η2 ≈ .02 is considered a “small” effect, an η2 ≈ .13 a “medium” effect, and an
η2 ≈ .26 a “large” effect [28]. Thus, the primary purpose of these analyses is to
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identify those instances (if any) in which a significant main effect for Device or
interaction with Device emerged, and to quantify the magnitude of Device-related
effects (i.e., η2 values) relative to Group- or RAC -related effects. Instances in
which “expected” sources of variance (i.e., main effects for Group and/or RAC )
had substantially larger effect sizes than main effects or interactions with Device
would indicate situations in which iRACE could serve as a viable alternative to
conventional gait analysis systems.
3.8.2 ANOVA Results
This section presents the key results regarding the accuracy of iRACE-derived
outcome measures relative to heel contact-derived outcome measures. Figure 3.9
plots group-level means and standard errors for each outcome measure, as a func-
tion of group (PD in red; HE in blue), RAC condition levels (x-axis), and device
(separate panels). η2 values for three simple effects (PD versus HE during self-
paced walking; self-paced versus 110% RAC in PD; self-paced versus 110% RAC
in HE) are highlighted for each outcome measure on Figure 3.9.
3.8.2.1 Group × RAC × Device ANOVA
The three-factor ANOVA enables a comparison of inter-group, inter-condition,
and inter-device variance for each outcome measure. Table 3.2 and Table 3.3
present the step time and step length ANOVA statistics, respectively. As expected,
significant group differences emerged in all four outcome measures: relative to HE
subjects, PD patients walked with slower steps (step time ∆M), shorter steps
(step length ∆M), and increased step time and step length variability (∆CV ).
Additionally, relative to self-paced walking, metronome-cued walking set to 110%
of self-paced cadence yielded significantly faster walking with longer steps and
less step-to-step variability. Effect sizes (η2 values) for Group were typically much
larger than for RAC , indicating a greater separation of outcome measure values.
Both ∆CV measures showed a significant main effect for Device, with iRACE
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Figure 3.9: Outcome measure results. Results of the Group (separate lines: PD vs.
HE) × Condition (x-axis: self-paced, 100% RAC, 110% RAC) × Device (separate
panels: iRACE vs. heel contact-based ground truth) ANOVAs for step time (a.) and
step length (b.) outcome measures.
showing inflated outcome measure values relative to heel contact-based devices.
The corresponding effect sizes, however, were small (η2 < .02), as were effect sizes
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Table 3. Statistics associated with the Group × RAC × Device ANOVA for step time outcome measures.  324 
 325 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 3.57 × 10-7 2.82 .108 < .001 4.03 × 100 5.01 .036 .013 
Group 5.99 × 10-2 12.41 < .001 .248 3.93 × 101 5.51 .028 .125 
Group × Device 5.96 × 10-8 .47 .500 < .001 2.34 × 100 2.34 .140 .006 
RAC 5.89 × 10-2 79.95 < .001 .243 1.79 × 101 6.04 .005 .057 
RAC × Device 7.71 × 10-7 2.18 .125 < .001 2.02 × 10-2 .06 .939 < .001 
Group × RAC 7.59 × 10-4 1.03 .366 .003 3.65 × 100 1.23 .302 .012 
Group × RAC × Device 1.13 × 10-6 3.19 .051 < .001 5.31 × 102 .17 .848 < .001 
 326 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold. 327 
  328 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
for all other interactions with Device.
3.8.2.2 Group × Device ANOVA during self-paced walking
This ANOVA quantified differences between PD and HE during self-paced walk-
ing, and whether that effect was significantly influenced by measurement device.
ANOVA statistics are presented in Table 3.4 and Table 3.5. η2 values for Group
were larger for ∆M statistics (> .41) than ∆CV statistics (< .22). Statistically
significant main effects for Device were present in step time ∆CV , step length ∆M ,
and step length ∆CV . However, the corresponding η
2 values for these significant
effects were all small (all η2 < .02), as were η2 values for all Group × Device
interactions.
3.8.2.3 RAC × Device ANOVA for PD patients
This ANOVA quantified the impact of RAC outcome measures of gait in PD,
and whether RAC effects were significantly influenced by measurement device.
ANOVA statistics are presented in Table 3.6 and Table 3.7. Significant main
effects for RAC were present in step time ∆M , step time ∆CV , and step length
∆M . Only step time ∆M showed a large (η
2 = .3067) effect size. All main effects
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Table 4. Statistics associated with the Group × RAC × Device ANOVA for step length outcome measures.  329 
 330 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 3.90 × 10-4 3.39 .079 < .001 13.74 × 100 25.27 < .001 .010 
Group 5.90 × 10-1 17.67 < .001 .416 3.05 × 102 8.49 .008 .225 
Group × Device 1.82 × 10-4 1.58 .221 < .001 5.93 × 10-1 1.09 .308 < .001 
RAC 4.90 × 10-2 28.01 < .001 .035 2.09 × 101 2.37 .105 .015 
RAC × Device 1.04 × 10-5 .26 .771 < .001 2.81 × 10-1 .43 .653 < .001 
Group × RAC 2.01 × 10-3 1.15 .326 .001 3.40 × 100 .39 .681 .003 
Group × RAC × Device 8.37 × 10-5 2.11 .133 < .001 4.48 × 10-1 .69 .508 < .001 
 331 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold. 332 
  333 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
Table 3.4: Statistics associated with the Group × Device ANOVA for step time
outcome measures during self-paced walking.
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Table 5. Statistics associated with the Group × Device ANOVA for step time outcome measures during self-paced walking.  334 
 335 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 6.16 × 10-8 .40 .533 < .0001 1.52 × 100 6.19 .020 .0111 
Group 2.68 × 10-2 15.71 < .001 .4166 2.64 × 101 5.64 .027 .1931 
Group × Device 5.59 × 10-7 3.64 .069 < .0001 3.65 × 10-1 1.48 .236 .0027 
 336 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold. 337 
 338 
  339 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
and interactions with Device had negligible effect sizes (all η2 < .01).
3.8.2.4 RAC × Device for HE subjects
For the sake of completeness, a RAC × Device ANOVA was performed for HE
subject data; ANOVA statistics are presented in Table 3.8 and Table 3.9. Main
effects for RAC were significant for both step time ∆M and step length ∆M , with a
substantially larger effect size for step time ∆M (η
2 = .3586). Unlike the previous
ANOVAs, Device had a strikingly large effect size for step time ∆CV (η
2 = .5099),
and a small-to-medium effect size for step length ∆CV (η
2 = .0848). In both cases,
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Table 3.5: Statistics associated with the Group × Device ANOVA for step length
outcome measures during self-paced walking.
17 
 
Table 6. Statistics associated with the Group × Device ANOVA for step length outcome measures during self-paced walking.  340 
 341 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 1.63 × 10-4 5.09 .034 .0004 2.93 × 100 5.88 .024 .0064 
Group 2.26 × 10-1 21.20 < .001 .4895 1.00 × 102 6.45 .019 .2198 
Group × Device 2.18 × 10-4 6.82 .016 .0005 8.00 × 10-3 .02 .900 < .0001 
  342 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold. 343 
  344 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
Table 3.6: Statistics associated with the RAC×Device ANOVA for step time outcome
measures in PD patients.
18 
 
Table 7. Statistics associated with the RAC × Device ANOVA for step time outcome measures in PD patients.  345 
 346 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 3.54 × 10-7 5.50 .039 < .0001 2.02 × 10-1 .17 .691 .0010 
RAC 3.34 × 10-2 40.12 < .001 .3067 1.80 × 101 6.10 .008 .0922 
RAC × Device 3.53 × 10-8 .13 .883 < .0001 5.81 × 10-2 .11 .898 .0003 
 347 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold. 348 
  349 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
Device effect sizes were larger than RAC effect sizes: outcome measures in HE
subjects were more affected by device-induced measurement error than they were
by the target RAC manipulation.
3.9 Discussion and Conclusion
This chapter presents the first-ever systematic ground truth validation of the accu-
racy of smartphone-based gait analysis in PD, and describes an iOS-based Rhyth-
mic Auditory Cueing Evaluation (iRACE) mobile application to facilitate RAC
efficacy diagnosis, via an assessment of upper motor (finger tapping) and lower mo-
tor (walking) performance. Novel machine learning-based gait analysis algorithms
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Table 3.7: Statistics associated with the RAC × Device ANOVA for step length
outcome measures in PD patients.
19 
 
Table 8. Statistics associated with the RAC × Device ANOVA for step length outcome measures in PD patients. 350 
 351 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 1.96 × 10-5 .34 .571 < .0001 4.31 × 100 8.42 .014 .0046 
RAC 2.87 × 10-2 18.32 < .001 .0517 1.77 × 101 1.29 .295 .0190 
RAC × Device 2.38 × 10-5 .84 .444 < .0001 1.13 × 10-2 .02 .982 < .0001 
 352 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold.  353 “SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
Table 3.8: Statistics associated with the RAC×Device ANOVA for step time outcome
measures in HE subjects.
20 
 
Table 9. Statistics associated with the RAC × Device ANOVA for step time outcome measures in HE subjects.  354 
 355 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 6.24 × 10-8 .33 .577 < .0001 5.71 × 100 14.41 .003 .5099 
RAC 2.63 × 10-2 40.97 < .001 .3586 3.55 × 100 1.19 .323 .0746 
RAC × Device 1.86 × 10-6 4.40 .025 < .0001 1.52 × 10-2 .15 .861 .0135 
 356 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold.  357 “SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
have been developed for iRACE, and the present pilot study reveals that iRACE
has low error rates relative to clinic-standard ground truth measures, indicating a
potentially useful clinical tool.
It is important to note that the present work is concerned with evaluating the
accuracy of smartphone-based gait measurement, not the efficacy of RAC (which
has been the focus of prior studies [100; 101; 141; 147]). RAC has been widely
noted for its facilitative effects on gait [62; 151]. iRACE enables medical pro-
fessionals to quickly and accurately quantify the degree of RAC facilitation (cf.
Section 3.8), enabling a decision of whether RAC might be useful as a “neuro-
physiological adjuvant” for individual PD patients.
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Table 3.9: Statistics associated with the RAC × Device ANOVA for step length
outcome measures in HE subjects.
21 
 
Table 10. Statistics associated with the RAC × Device ANOVA for step length outcome measures in HE subjects. 358 
 ΔM ΔCV 
Effect SS F p η2 SS F p η2 
Device 5.53 × 10-4 3.20 .101 .0020 1.00 × 101 17.42 .002 .0848 
RAC 2.23 × 10-2 11.55 < .001 .0815 6.55 × 100 1.70 .205 .0555 
RAC × Device 7.02 × 10-5 1.38 .273 .0003 7.18 × 10-1 1.08 .356 .0061 
 359 
“SS” is the portioned sums of squares for each ANOVA term. Significant p-values are highlighted in bold.  360 “SS” is the portioned sums of squares for each ANOVA term. Significant p-values are
highlighted in bold.
The flexibility, portability, and validity of iRACE suggest both prognostic and
analytic applications. First, because it is smartphone implemented, an entire
world of RAC stimuli can be made available, ranging from the user’s own music
collection to commercially available streaming music (e.g., Deezer2, Google Play3,
Spotify4), matched to the user’s music preference and the requirements of RAC
therapy (e.g., steady tempo and strong beats).
Second, iRACE could be used to track the improvement of motor performance
over time (e.g., in a longitudinal clinical trial) or in conjunction with a behavioral,
pharmacological, or neurostimulatory intervention.
Third, iRACE would enable clinicians to evaluate correlations between (1)
upper motor and lower motor timing variability, and (2) step time and step length
variability during gait, both of which remain largely unexplored in the clinical
literature.
Fourth, the portability of iRACE would enable it to be used by neurologists
and physical therapists around the globe. The resultant surge in collected data
(archived and managed on the iRACE website; cf. Section 3.2) could then be used





potentially novel insights into how PD affects the motor system. Together, this
future work may lead to an improved ability to characterize—and, ultimately,







Mobility assessment is a standard non-invasive PD test, which aims to quan-
tify movement and give a clinical measure that reflects the degree of mobility
impairment. It includes the quantification of both the lower and upper motor
performance. Specifically, for lower motor performance, stride (and step) time
and length are the most fundamental and important measures. Additionally, gait
variability measures such as traditional statistical quantities (e.g. coefficient of
variation) are extremely useful for clinical evaluation.
Experiments have shown that even whilst on medication PD patients show a
reduction in gait parameters such as cadence and stride length relative to age-
matched healthy controls [129; 109]. In addition, PD patients attempting to per-
form motor tasks at a constant rate show larger variation than healthy controls
performing the same tasks. For example, a study showed that PD patients have a
larger step time variability (7%) than healthy controls (4%) [47]. Gait measure-
ment in a clinical setting is normally quantified using pressure sensitive walking
mats [111], heel-mounted force-sensing sensors (or footswitches) [73], or motion-
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capture cameras [117]. All of these systems are costly, non-portable, often require
either technical or clinical expertise to use, and as a result do not scale easily. How-
ever, Inertial Measurement Unit (IMU) based cyber-physical systems have shown
great utility in medicine, and are inexpensive, scalable, portable, and importantly
can be used outside of the hospital [41].
Medical specialists such as neurologists are a scarce resource in most developing
countries. Rural and community hospitals in such countries are ill equipped to
make an accurate diagnosis of PD or even perform a mobility assessment, forcing
(often frail) PD patients to travel a long distance to hospitals in large cities such
as Shanghai or Mumbai. To address this critical need, we propose a cost effective
and easily deployable IMU-based system dubbed MANA (Mobility ANAlytics)
to connect the PD patients in remote communities with specialists in large cities
leveraging on the general clinicians in rural or community hospitals. Community
hospitals equipped with MANA thus will be able to provide expert diagnosis
and mobility assessment locally, eliminating the need for patients to travel long
distances. The key contributions of this work can be summarized as follows:
1. We established an all-in-one cyber-physical system for mobility analysis,
including an IMU-based body sensor network (two sensors embedded in the
shoes, two on the wrists, and one on the waist), a mobile application and a
web service for data analysis and visualization. We designed and developed
these sensor boards to be small, wearable, and cost-efficient.
2. We proposed novel and accurate gait analysis algorithms by fusing accelerom-
eter and gyroscope data, combining multiple sensors, and utilizing kinematic
constraints (such as the fact that the shoe-embedded sensor is stationary
at middle-stance). The algorithm accuracy (mean absolute error of stride
length: 5.7 cm, and step length: 3.8 cm) outperformed existing methods.
3. We built a classifier based on the combined foot and hand sensor data, and
achieved 90% accuracy in classifying subjects into six severity groups, which
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represents the most complete and most clinically relevant PD severity group
classification in the literature. A binary classifier was also used to split the
subjects into two severity groups (98%-100% accuracy). We also built a
regression model to predict the Universal Parkinson’s Disease Rating Scale
(UPDRS) motor score, with a mean absolute error of 5 points.
4. We validated our system and algorithms in a clinical trial with 60 subjects
(40 PD patients), which is one of largest studies of its type. The system is
low-cost, wearable, scalable, and suitable for long-term use in hospital and
home settings.
The next section describes the MANA system. Our gait analysis methods
for temporal gait parameters are presented in detail in Section 4.3. Spatial gait
analysis methods are proposed for stride and step length estimation in Sections 4.4
and 4.5 respectively. Section 4.6 investigates the classification of PD severity
and estimation of UPDRS motor score. Section 4.7 discusses the clinical trial
undertaken in this study, and describes the procedure of the trial. Experimental
results are presented in Section 4.8. Finally, Section 4.9 concludes our work and
explores future directions.
4.2 System Description
To overcome the shortcomings of the systems described in Section 2.2 we propose
an IMU-based cyber-physical system (MANA) for gait analysis and PD severity
classification. We designed MANA to be inexpensive, portable, and convenient,
making it possible to be employed by the doctors in rural hospitals or by the







Figure 4.1: An overview of MANA.
4.2.1 Design and Outline
MANA consists of a series of physical devices, communication protocols, motion
analysis algorithms, and software applications. MANA has three main physical
components: wearable IMU sensor boards (MANA sensors), an application run-
ning on a mobile device (MANA Collator), and a web application hosted on cloud
servers (MANA Hub) (see Figure 4.1). A subject can wear the MANA sensors
to record the motion data, and MANA sensors use the Bluetooth Low Energy
(BLE) protocol to upload the data to a smartphone via the installed Collator app.
The Collator further uploads the data to the server for real-time processing, and
the results are sent back to the Collator and also visualized in the web applica-
tion, where both the patient and the doctor have access. This is a closed-loop
of real-time data collection, analysis, and feedback to the user. Our goal with
MANA was to design an inexpensive, portable and scalable mobility assessment
system built on open standards such as BLE and websockets so that it is platform






Figure 4.2: Sensor photos. (a.) Sensor board. (b.) Sensor case. (c.) Wrist band for
sensor case. (d.) Sensor case embedded in the center of a shoe.
access to the underlying hardware, allowing custom motion analysis software (e.g.,
fall detection) to be run directly on the sensor.
4.2.2 MANA Sensors
The MANA sensor (see Figure 4.2) includes an IMU chip (InvenSense MPU-6050
model with an integrated triaxial accelerometer and gyroscope), a BLE module
(RFduino RFD22301), an EEPROM chip, and a micro USB port for uploading
program and charging battery. All these components are assembled on a Printed
Circuit Board (PCB), as shown in Figure 4.3. The sensor is powered by a 3.7v 110
mAh lithium-ion polymer battery. The sensor records accelerometer and gyroscope
data and sends the data back to the Collator via BLE. The sensor board has a small
size of 23× 20× 6 mm. A custom plastic case is manufactured to encapsulate the
sensor board together with the battery. A wrist band is used to mount the sensor
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Figure 4.3: Sensor board circuit design top view (left) and bottom view (right).
case so that it can be worn comfortably like a watch. The sensor case is strong
enough so that it is able to withstand the force of footfalls whilst being embedded
in shoes during walking. The sensor has an integrated USB port (accessed through
the case) to easily upload programs and charge the battery. The battery can be
fully charged in 2 hours, and lasts 8 hours for data streaming (i.e., about a week
if one hour of mobility evaluation/data streaming per day, and standby during
the rest of time). Batteries of larger capacities can be used if needed. With the
unobstructive wearable design and easy battery charging, the MANA sensors are
feasible for long term use.
The MANA sensor was designed to support BLE rather than a normal Radio
Frequency (RF) module because most modern smartphones support the Bluetooth
protocol and therefore no additional costly hardware is required to communicate
with the sensors and collect data. Furthermore, BLE consumes less power than
classic Bluetooth (Bluetooth 2.0). We do not use a magnetometer as they are
easily susceptible to magnetic interference which can limit the accuracy of orien-
tation estimates [26], but this does not preclude us estimating stride length as is
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demonstrated in Section 4.4.
During data collection, the sensor samples the IMU at 100 Hz, and streams
the 3-axis accelerometer and 3-axis gyroscope readings together with the sampling
timestamp to the Collator. Transmitting raw sensor data to the Collator in real-
time is a challenge for the limited bandwidth of BLE, especially when multiple
sensors stream data simultaneously to the same Collator. To maximize the use
of available bandwidth and reduce power consumption, the sensors compress the
IMU data before transmission. The compression technique works by sending the
differences in adjacent IMU readings (and adjacent timestamps) rather than the
raw values, and thus it requires much fewer bytes to represent the data.
Due to the limitation of GATT characteristic reading to 20 bytes, only 20
bytes can be sent within each time slot. To fully utilize the BLE bandwidth,
multiple IMU samples are combined into a data packet, and multiple data pack-
ets are placed into a sending buffer to be sent together. Exactly 20 bytes are
taken from the sending buffer and sent in each time slot, so that no bandwidth
is wasted. Each data packet contains a sequence number, so that packet loss can
be detected. As a result, the compression technique can reduce the data size (and
thus required bandwidth) by a factor of two to three during walking data collec-
tion. In our experiment, we can stream from five sensors simultaneously to the
same Collator without data loss using the compression technique, while data loss
occurs frequently if compression is not used.
Since the sensor’s hardware clock stops when the battery is turned off, each
sensor will keep a different local time. In our system, every sensor clock is synchro-
nized to the Collator smartphone clock via a simple synchronization protocol [145].
Specifically, the Collator sends a “get-time” command to the sensor, and the sen-
sor immediately replies with its local time. The Collator also records the time of
the smartphone when the command is sent and when the reply is received. This
procedure is repeated multiple times before and after data collection. With the
resultant timestamp dataset, we can use linear regression to find the best align-
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ment of the sensor time to the smartphone time (by calculating an offset and a
scale factor of the sensor time). The error bound of the synchronization is ap-
proximately 10 ms, which is accurate enough to align the movement recorded by
different sensors (e.g., left and right steps).
For the needs of our system, our sensors have many benefits over other com-
mercial products. They are inexpensive even before mass production (less than
USD $100), they permit us to use wireless transmission, and they are completely
programmable. This last feature is critical as in future work we intend to develop
more sophisticated onboard algorithms for gait evaluation and detection.
4.2.3 MANA Collator and Hub
The Collator is a mobile application that can run on any smartphone that supports
BLE. It collects the data from sensors over BLE and then uploads the data to the
Hub. It is currently implemented on the Android platform and has been tested on
the most common Android phones (such as the Samsung Galaxy S series). During
normal operation, the application runs in the background collecting data from the
sensors, and if it has access to the internet it will securely transfer the recorded
data to the Hub.
The Hub is a web based application for storing, processing and viewing the data
recorded by the MANA sensors. It has an accounts and permission system to only
allow a patient’s data to be seen by those with appropriate authorization (such as
a patient himself/herself or the doctor of that patient). Additionally, there is an
anonymizer system to generalize data for research purposes. The system supports
both historical (or archived) data for later analysis and live streaming for real-time
data acquisition and processing. The Hub can compute the gait parameters (e.g.,
stride time and stride length) immediately after each stride, and stream them
back to the Collator in real-time. A set of communication protocols are defined
and implemented between the Sensor, Collator and the Hub, so that the user can
easily control the sensors from both Collator and the Hub.
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By connecting the wireless MANA sensors to smartphones and cloud services,
MANA becomes an all-in-one system with access to both real-time motion track-
ing and almost unlimited computing power, allowing sophisticated temporal and
spatial gait analysis to be performed.
4.3 Temporal Gait Analysis
One of the key functionalities of MANA is gait analysis. The first step of analysis
involves segmenting each stride from the IMU data, and identifying each stage
in a gait cycle. After that we can calculate the temporal gait parameters (e.g.,
step and stride time) and spatial gait parameters (e.g., step and stride length).
This section describes the IMU data processing pipeline for temporal gait analysis.
Spatial gait analysis will be detailed in later sections.
4.3.1 Preprocessing
Before the accelerometer and gyroscope data can be analyzed by our algorithms
it must first be calibrated, then converted to a consistent reference frame. Then
the data is separated into straight line walking segments, and into non-walking
segments.
4.3.1.1 Accelerometer and Gyroscope Calibration
Each axis i of an accelerometer or gyroscope has a bias (bi) and scale factor (fi),
which are required to adjust the raw sensor measurement (V rawi ) to the calibrated
value (V calibi ) for further processing:
V calibi = fi(V
raw
i − bi). (4.1)
For low-profile inertial sensors such as the ones used in our system, the sensor











Sensor Location a.	 b.	
Figure 4.4: (a.) Sensor mounting locations on the body. (b.) Global frame (green)
and sensor body frame (red).
temperatures or even after every sensor switch-on. Although field calibration after
each switch-on is more accurate than a one-time lab calibration, it is impractical
in clinical experiments or real applications due to its high complexity and long
duration.
Thus we conduct a one-time lab calibration to obtain the baseline parame-
ters for each sensor, and use these parameters to adjust the raw sensor measure-
ments. Since in each data collection session, the actual sensor parameters may
vary slightly, we introduce bi and fi as variables in our sensor models and fine
tune them in each session, as described in Section 4.4.
To perform this one-time lab calibration of each axis of the accelerometer and
gyroscope, we build a platform with two servos, which can be programmed to
rotate in two degrees of freedom (DoF). Then we affix the sensor board on the
platform, and use the sensor readings when the platform is stationary or rotating
























































Figure 4.5: Example accelerometer (left) and gyroscope (right) waveforms during
walking from 3 sensors attached to the left foot, right foot and waist (per row).
4.3.1.2 IMU Coordinate System
The next step is to change the IMU coordinate system to one that is more intuitive
and straightforward. Each shoe sensor is embedded in the shoe such that three
IMU axes are approximately parallel with the forward, leftward and upward direc-
tions of the subject, respectively. The sensor body frame constructed by the three
IMU axes is denoted by {B}. For simplicity and convenience, from the subject’s
perspective, we define the three IMU axes as anterior-posterior (AP) axis (ante-
rior as positive direction), left-right (LR) axis (leftward as positive direction), and
up-down (UD) axis (upward as positive direction), which are denoted by
#    –
APB,
#   –
LRB and
#    –
UDB, respectively (Figure 4.4b). These three axes form a right-handed
Cartesian coordinate system. The sign of the raw IMU readings may be flipped to
comply with the definition of the positive directions of the axes of {B}. Thus the
3-axis acceleration can be denoted by aAP , aLR and aUD, respectively. Note that
the accelerometer we are using outputs +1g (where g is the acceleration due to
gravity) in the UD axis when it is stationary. Similarly, the 3-axis rotation rates
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measured by gyroscope are denoted by ωAP , ωLR and ωUD, respectively. Example
accelerometer and gyroscope waveforms are shown in Figure 4.5.
Since the time interval between successive IMU samples varies slightly (even
though the IMU is configured to sample at a constant rate), the raw IMU data
is usually interpolated and resampled at a higher fixed frequency [76; 110]. In
our study, all IMU data was cubic-spline interpolated and resampled at 1000 Hz,
and then low-pass filtered at a cut-off frequency of 10 Hz, as is common in most
studies [165; 166].
4.3.1.3 Straight Line Walking Segmentation
We focus only on the analysis of gait data during straight-line walking. Therefore,
a program was developed to separate straight-line walking segments from non-
walking segments such as turn segments (cf. Figure 4.8c) and stationary segments.
This separation was achieved primarily based on manually selected thresholds of
the acceleration amplitude (to remove non-walking segments) and rotation rate
(to identify turning). The program was validated against the ground-truth seg-
mentation obtained by annotating the videos of the subject walking (described
in Section 4.7.2). Since the patterns of different walking segments are relatively
prominent and clear in the walking dataset collected in this study, this straight-line
walking segmentation program achieved close to 100% accuracy.
4.3.2 Gait Cycle Analysis
Temporal gait analysis involves the segmentation of each individual stride (known
as a gait cycle) from the IMU data. Figure 2.7 illustrates different phases in a full
gait cycle, such as swing/stance phases and single/double support phases. These
gait phases are separated by Toe-Off (TO) and Heel-Strike (HS) events. The step
time is the duration between two successive HS of the two feet, while the stride
time is between two successive HS of the same foot. The stance phase of one foot is
from its HS to its TO. The swing phase of one foot is from its TO to its HS, which
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corresponds to the single-support phase of the other foot. The double-support
phase is between the HS of one foot and the TO of the other foot. The duration
of each phase in the gait cycle can be directly obtained from the TO and HS times
of both feet.
As shown in Figure 4.6, each TO and HS event in a stride causes a predominant
peak and trough in the aAP waveform respectively. The peak and trough points
can be located using a simple peak detection algorithm. To find a stable and
reliable correspondence points of the TO and HS events in the aAP waveform,
we use the sharpest rising point (i.e., with the largest slope) in the rising edge
preceding the peak point as the correspondence point of a TO event, and use the
sharpest rising point in the rising edge after the trough point as the correspondence
point of a HS event.
Whilst a single sensor attached to the waist at the navel position can also be
used by itself to detect steps and strides and even identify left-vs.-right foot [163],
it is usually not as straightforward and accurate as detection based on two foot-
attached sensors. This is a clear advantage of our sensor system which allows
the whole gait cycle to be clearly defined, as shown in Figure 4.6. This complete
gait cycle analysis cannot be achieved by a single sensor on one foot or on the
waist. For example, one sensor cannot detect strides of the opposite foot or the
steps. Moreover, double-support time and single-support time of the opposite foot
cannot be inferred from one sensor.
After gait cycle analysis, statistics of an entire walking session can be calcu-
lated, such as step count, cadence (steps per minute), variation of step time, and
swing/stance time ratio. The comparison of these parameters between two feet
(e.g., left/right step time ratio) can also be performed. To clinicians, these results
of the temporal analysis provide comprehensive insights of the gait dynamics and
walking style of the subject and subsequently to the subject’s health condition.
For instance, some PD patients are more impaired on one side of the body than
the other, and as such they tend to have imbalanced gait, which is usually reflected
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Figure 4.6: Gait cycle segmentation based on Heel-Strike (HS) and Toe-Off (TO)
events from AP acceleration of left (L) and right (R) feet.
as a large difference between some or all gait parameters of two feet.
4.4 Stride Length Calculation
Now that the gait cycle of each stride is clearly defined, we can calculate stride
length, which is an important and fundamental spatial gait parameter. As re-
viewed in Section 2.3, the position of the IMU affects the accuracy of stride length
estimation [125]. To mitigate this IMU position problem, we embed the sensor
in the bottom of a shoe, which enforces several kinematic constraints that can
be utilized in our algorithms. This section describes two stride length algorithms
based on double integration and kinematic constraints, which use the data from a
single shoe-embedded sensor.
4.4.1 Transformation Between Coordinate Systems
As stride length is measured in the global reference frame (denoted by {G}), we
must transform the IMU acceleration from the sensor body frame to the global
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frame. Assuming straight-line walking on level ground, a global coordinate system
{G} can be established with its AP axis ( #    –APG) pointing forwards along the walking
line, its LR axis (
#   –
LRG) pointing leftwards of the subject, and UD axis (
#    –
UDG)
pointing upwards (parallel with gravity direction). During straight-line walking,
the global coordinate system {G} is fixed, while the sensor body frame {B} rotates
along with the shoe. The acceleration recorded by the IMU is represented in {B},
while the spatial gait parameters such as stride length are represented in {G}.
Thus the first step is to transform the acceleration into {G}.
Three unit vectors co-directional with the three axes of {G} can be repre-
sented in {B} as eAP = [eAP1 , eAP2 , eAP3 ]T , eLR = [eLR1 , eLR2 , eLR3 ]T and eUD =
[eUD1 , eUD2 , eUD3 ]
T , respectively. Note the superscript B of these three vectors is
abbreviated without causing confusion since their representations are only used
in {B}. A transformation matrix R can be constructed by using the transpose of















Establishing the relationship between R and each row in R is important for
deriving the following stride length algorithms, especially the methods to update
R over time. The representation of a vector in {B} (denoted by rB) can be
transformed to its representation in {G} by
rG = RrB. (4.3)
Thus the acceleration vector aB = [aAP , aLR, aUD]
T measured by IMU in {B}
can be transformed to acceleration in {G} as aG = RaB. Double-integrating aG
gives the distances traveled in the global frame, such as stride length.
The stride length is the distance between two stance positions of the same foot.
95
As the foot sensor is embedded in the shoe, the sensor stays stationary during the
stance phase of the foot, and therefore all axes of IMU data do not vary much.
This is clearly shown in Figure 4.6 as the segment of the waveform which is flat
and approximately zero for both accelerometer and gyroscope. Thus, we define
the middle time point of the stance phase as the “zero point”, because at “zero
point” the gravity-removed acceleration, velocity and rotation rate of the IMU
can all be regarded as zero. This definition is consistent with the “zero velocity
assumption” [71] and the Zero Velocity Update method (ZUPT) at mid-stance
that are widely adopted by many studies for foot-mounted IMU analysis. Unlike
our study, the IMU in those studies is attached to the back of the heel or the
ankle position, causing the IMU to slowly rotate during stance. In general, the
higher the sensor is attached on the foot, the faster the sensor rotates at stance.
Research has shown that multiple significant modeling errors are related to the
ZUPT methods [125]. By contrast, our shoe-embedded IMU has almost constant
readings at “zero point”, which results in smaller errors and justifies the use of
the “zero velocity assumption”.
As our goal is real time gait analysis, we estimate the stride length based on
the IMU data between two successive zero points. During walking, R changes in
time, and is denoted by R(t) at time t. Time t starts from 0 (at the beginning of
the stride) and ends at T (at the end of the stride). First, we need to determine
R(0), i.e., the values of eAP , eLR and eUD at time t = 0.
Since the IMU is assumed to be stationary in the beginning of a stride, the
acceleration measured by IMU is purely acceleration due to gravity. Thus, the
acceleration a(0)B = [aAP (0)
B, aLR(0)
B, aUD(0)
B] should be co-directional with




where ‖·‖ is the Euclidean norm.
To derive eAP (0), we introduce a parameter θ as the angle between the AP
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axis of {B} ( #    –APB) and the direction vector rOA which is the line of intersection
between the plane (PGUD,AP ) formed by UD and AP axes of {G} and the plane
(PBAP,LR) formed by AP and LR axes of {B}, as shown in Figure 4.4b. Usually θ
is relatively small as the IMU is embedded in the shoe such that
#    –
APB is almost
co-directional with
#    –
APG. The parameter θ will be determined differently later as
described in Section 4.4.2 and Section 4.4.3, respectively. Note that different from
many other studies, we do not need to use a magnetometer to decide the direction
of eAP (0).
The direction vector rOA is represented in {B} as
rOA = [cos(θ), sin(θ), 0]
T . (4.5)
Note that eAP , eUD and rOA are all within plane PGUD,AP , and eAP⊥eUD, thus
eAP (0) can be derived by
eAP (0) =
(eUD(0)× rOA)× eUD(0)
‖(eUD(0)× rOA)× eUD(0)‖ . (4.6)
Subsequently, eLR(0) is decided by
eLR(0) = eUD(0)× eAP (0). (4.7)
AfterR(0) is obtained, given the IMU rotation rate ω(t) = [ωAP (t), ωLR(t), ωUD(t)]
measured by the gyroscope at time t, R(t) can be updated iteratively by
R(t+ dt) = R(t)

1 −ωUD(t)dt ωLR(t)dt
ωUD(t)dt 1 −ωAP (t)dt
−ωLR(t)dt ωAP (t)dt 1
 , (4.8)
where dt is a small time interval between two IMU samples [106; 139].
Note that Equation (4.8) integrates ω(t) over time, which may cause an accu-
mulated estimation error of R(t) due to the noise in ω(t) and the errors of numer-
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ical integration. This is the main source of error in this stride length estimation
approach and the next subsections will detail different methods to compensate for
it.
4.4.2 Reset-based Stride Length Algorithm
The key idea of the Reset-based Stride Length Algorithm is to linearly reset the
gravity-removed acceleration and velocity to zero at the end of each stride, which
is a zero point. First, to determine R(0), this algorithm assumes the parameter
θ = 0 as θ is usually small, which simplifies Equation (4.5) as rAP = [1, 0, 0]
T .
After obtaining R(t) as described in 4.4.1, given the acceleration at time t
represented in {B} as a(t)B = [aAP (t)B, aLR(t)B, aUD(t)B]T , the acceleration in
{G} can be obtained by
a(t)G = [aAP (t)
G, aLR(t)
G, aUD(t)
G]T = R(t)a(t)B. (4.9)
The acceleration with gravity removed in the UD axis is
a(t)G− = [aAP (T )
G, aLR(T )
G, aUD(T )
G − g]T . (4.10)
As mentioned before, R(t) usually drifts over time, which can cause increasing
estimation errors of a(t)G−. At the stride ending time t = T , a(T )
G
− may be far
from zero, even though based on the zero point assumption, it should be close to
zero. To mitigate this drift problem, the following linear resetting function h0(·)
is applied to a(t)G− to force a(T )
G
− to zero:
h0(x(t)) = x(t)− t
T
x(T ), (4.11)
where x(t) is a time series with t between 0 and T .
Next, since the initial velocity of the IMU at a zero point is assumed to be
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zero, the velocity is given by







Similarly, to mitigate the integration drift, h0(·) is applied to v(t)G to reset v(T )G
to zero. Finally the displacement of a stride is obtained by







For an ideal straight-line walking on a level ground, sLR(T )
G and sUD(T )
G
should be zero at the end of a stride, and the stride length should equal to sAP (T )
G.
However in practice, sLR(T )
G and sUD(T )
G are usually not zero. To better esti-
mate the stride length (L), the Euclidean norm of s(T )G is used, i.e.,
L =
∥∥s(T )G∥∥ . (4.14)
4.4.3 Optimization-based Stride Length Algorithm
The Optimization-based Stride Length Algorithm utilizes a sensor fusion model
with parameters and then optimizes these parameters based on kinematic con-
straints. As mentioned in Section 4.3.1.1, the sensor bias and scale factor may
change under different environments, or even after each switch-on. To account
for these variable sensor properties, we first process the sensor data using the
following models. The acceleration model used in this method is given by
ai = (1 + f
Acc
i )(a˜i − bAcci ) (4.15)
where i is one of the AP, LR or UD axis, a˜i is the IMU-measured acceleration
after preprocessing (cf. Section 4.3.1), bAcci is the bias, and f
Acc
i is the adjustment
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of the scale factor. Similarly the model for rotation rate ωi is
ωi = (1 + f
Gyro
i )(ω˜i − bGyroi ). (4.16)
The 12 model parameters Ω = {bAcci , fAcci , bGyroi , fGyroi }i will be estimated later.
As the sensor data has been calibrated during preprocessing, Ω is close to zero.
As described in Section 4.4.1, parameter θ is introduced to calculate R(0). Unlike
the Reset-based algorithm which simply assumes θ = 0 (cf. Section 4.4.2), the
Optimization-based algorithm keeps θ as a variable that can be decided later.
Another advantage of this method is that it does not rely on the orientation of the
shoe-embedded IMU, and theoretically it also supports non-straight-line walking.
Using the same method described in Section 4.4.2, the displacement can be
derived from acceleration via Equations (4.9), (4.10), (4.12) and (4.13), with the
exception that the resetting function h0(·) is not applied to a(t)G− or v(t)G.
Since the end of a stride is a zero point, the model parameters Ω and θ can be
determined based on the following constraints:
1. The gravity-removed acceleration a(T )G− should be zero.
2. Velocity v(T )G should also be zero.
3. As the AP axis of {G} is co-directional with the walking direction and
sAP (T )
G provides the whole stride length, sLR(T )
G and sUD(T )
G should
be zero.
4. Similarly, a(T )B and eUD(T ) should be co-directional, which means the
angle between them should be zero, which is calculated by
φ = arccos
a(T )BeUD(T )
‖eUD(T )‖ ‖eUD(T )‖ . (4.17)
To combine these constraints as well as regularize the model parameters, an
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error vector can be formed as
 = [a(T )G−,v(T )
G, sLR(T )
G, sUD(T )
G, φ,Ω, θ]. (4.18)
Every element in  is close to zero, including the model parameters. In order
to control the influence of an individual constraint and apply different penalties to
the model parameters, a new error vector ′ is formed by an element-wise product
(◦) of a weight vector λ (which can be chosen empirically) and :
′ = λ ◦ . (4.19)
The model parameters Ω and θ are determined such that the following cost
function (i.e., the norm of the error vector) is minimized:
J(Ω, θ) = ‖′‖ . (4.20)
In practice, instead of optimizing the norm ‖′‖, the vector ′ can be directly
used for least-squares optimization1 (such as using the Levenberg–Marquardt al-
gorithm [120]). Finally, after the model parameters Ω and θ are determined, the
stride length is calculated by sAP (T )
G.
4.4.4 Linear Regression of Stride Length Estimation
In the previous two approaches (Reset-based and Optimization-based stride length
algorithms), we found that the derived stride lengths have a mean error of approx-
imately 2 cm, instead of zero (see the results in Section 4.8 and Table 4.1). The
underestimation of stride length is likely caused by several reasons. For exam-
ple, since the IMU data is low-pass filtered in the preprocessing step in order to
remove noise, the amplitude of the resultant data is inevitably reduced to some
extent, which leads to a reduction in stride length estimation. Another source of
1 Using function scipy.optimize.leastsq in the scipy library.
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this underestimation is that in reality the velocity at zero points may be slightly
larger than zero for some strides, thus resetting the velocity to zero can cause
underestimated stride length.
In order to compensate for this underestimation, we tried to fit a model to map
the initial stride length estimation (L′) to the ground-truth stride length (L). Since
this is a simple mapping between two scalar variables, we used a linear regression
model. Specifically, different degrees of polynomial regression models were trained
and evaluated, and we selected simple linear regression (i.e., L = αL′ + β) for its
accuracy and efficiency, where the coefficients α and β are determined using least
squares fitting.
To obtain a stable model evaluation and reduce the effect of over-fitting, 10-
fold cross-validation is used to train and test the linear regression model. Cross-
validation is a model validation technique for assessing how well a model can
generalize to an independent dataset, and it is used to evaluate all the models we
proposed in this study. The dataset is split into ten partitions of equal size. A
partition is selected and saved as the test set, and the model is trained using the
remaining nine partitions. This process is performed ten times (for each partition),
and ten test results are averaged to produce a single estimation of the model
performance. When splitting the training and testing data in cross-validation,
two splitting methods are used and then compared to see whether data from
unseen subjects affects the accuracy (i.e., to estimate the model generalizability
to new subjects in the future):
• Subject-based splitting where the strides of a subject are present only in the
training or testing data.
• Non-subject-based splitting where the strides of a subject are present in both
training and testing data.
The experimental results of the stride length algorithms as well as the linear
regression models will be presented in Section 4.8.
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4.5 Step Length Calculation
Step lengths (as distinct from stride lengths) are another important spatial gait
parameter for clinicians to evaluate gait abnormality [107; 116]. As described in
Section 4.4, stride length can be calculated analytically based on the zero point
constraints using a shoe-embedded sensor. However, it is not as straightforward
to calculate the step length between alternating feet purely based on two shoe-
embedded sensors, since one sensor can only measure the movement of the foot
that it is mounted on and it is difficult to align the two sensor positions in space.
In the MANA system, the waist-mounted sensor can be used to measure step
length since the waist sensor captures the movement of both feet. Nevertheless,
the method in Section 4.4 relies on the assumption that the IMU is stationary at
the middle of stance and thus it is not suitable for step length calculation using
the waist sensor, because the waist sensor keeps moving forward even during the
foot stance phase (cf. Figure 4.5).
To calculate step length based on the waist sensor, machine learning-based
regression methods can be used, which have been adopted by many studies for
IMU-based displacement measures, including step length and stride length [163].
In this section, we present a comprehensive analysis of the regression-based step
length calculation method. For each step of a foot, the movement is recorded by
both the waist sensor and the foot sensor embedded in the shoe of that foot. To
take advantage of the multiple sensors attached to the body, we use both waist
and foot sensors to calculate step length, and compare the following two regression
methods:
• Step length modeling using the waist sensor alone.
• Step length modeling using the waist sensor and the foot sensor on the same
side of the step.
For each step, we extract features from the IMU waveforms of the waist sen-
sor or both waist and foot sensors (as described above). For the 3 acceleration
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waveforms (and similarly for the 3 rotation rate waveforms), the first and sec-
ond integral of each waveform as well as the energy waveform (i.e., the Euclidean
norm) are used. Features extracted from each waveform are similar to those in
existing studies [163], such as the min, max, mean and standard deviation of each
waveform.
From a vast variety of existing machine learning algorithms, we choose to use
Multi-layer Perceptron (MLP) to build our regression and classification models
in this study, due to its flexible configuration and modeling capability (from a
single layer network to dozens of layers as in deep neural networks), as well as
its wide applications (with validated performance) in gait analysis (e.g., [146;
163]), so that it can work as a representative model to evaluate the modeling
capability of the sensor data, and also provide comparison to existing studies. We
use the scikit-learn library [134] to train the regression model based on the
Multi-layer Perceptron (MLP)2. A processing “pipeline”3 is constructed with the
following 3 steps:
1. Feature standardization by centering and scaling the features to zero mean
and unit variance.
2. Feature dimensionality reduction using Principal Component Analysis (PCA).
3. Training and evaluation of the regression model.
To mitigate the over-fitting problem, 10-fold cross-validation is used to evalu-
ate the model performance. Different combinations of the model parameters are
evaluated based on cross-validation, such as the number of components used in
PCA, the number of hidden layers and number of neurons in each hidden layer.
Note that in each fold of cross-validation, the parameters of the whole process-
ing “pipeline” (including feature standardization and PCA) are trained purely on




model training. Similar to the case of stride length estimation (Section 4.4.4),
the training and testing data is split in two ways, subject-based and non-subject-
based. The average performance of the models based on cross-validation will be
presented in Section 4.8.
4.6 PD Severity Classification and UPDRS Regres-
sion
Another important task for PD diagnosis is the classification of the severity of a
patients PD. This commonly requires expert knowledge and many specialist con-
sultations. In the following subsections we describe the method used to estimate
the severity group based on IMU data.
4.6.1 PD Severity Groups
PD is a chronic disease and it progresses slowly. In our study, PD patients are
split into four severity groups corresponding to the Hoehn and Yahr stages 1
to 4 (a subsection of the UPDRS) [63]. Stage 5 implies confinement to bed or
wheelchair unless aided, and therefore is excluded in this study. Here we abbreviate
the four groups as PD1, PD2, PD3 and PD4 respectively. These groups are
characterized by an increase in gait abnormality, presence of tremor, bradykinesia,
and other common symptoms. In our experiment we also consider two other groups
Healthy Controls (HC) and Rapid-eye movement sleep Behavior Disorder (RBD,
a precursor to PD). In total six groups of subjects are studied, ranking based on
the PD severity: HC, RBD, PD1, PD2, PD3, and PD4.
4.6.2 Classification of Subject Groups
Unlike most studies on PD severity classification which separate the patients into
two severity groups [140; 23], this paper represents the first attempt to classify the
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subjects into six groups, which are the standard clinical severity groups used by
doctors. Since the six severity groups are ordered, we investigate two classification
schemes from different clinical perspectives.
The first classification scheme is the binary split classification. A severity
group is used as the threshold to split all the groups into two categories: a less
severe category consisting of groups less severe than the threshold, and a more
severe category consisting of the remaining groups. The groups in a category
are close to each other in severity. The threshold group has five choices (RBD,
PD1, PD2, PD3, or PD4), and a binary classifier is built for each split to classify
the two categories. This scheme investigates the separation ability of different
thresholds (and thus providing insight regarding the severity group ordering), and
also provides a direct comparison with existing studies. In this scheme, since the
sample sizes are imbalanced for the two categories, a bootstrapping technique is
used to oversample (i.e., duplicate) the subjects in the smaller category such that
the total sample sizes are balanced. This helps the classifiers to converge and also
obtain stabilized testing results (e.g., avoid over-fitting to the majority class). The
performance of the classifiers is evaluated using cross-validation as usual.
The second classification scheme is multi-class classification. In this scheme,
we aim to use only one classifier to predict a subject’s group. The output group of
the classifier has six choices (HC, RBD, PD1, PD2, PD3 or PD4), which is more
technically challenging and uncommon in the literature. Each group is treated
independently, and the severity ordering among the groups is not considered in
the training of the classifier. This method is the most useful for clinicians because
it is the equivalent of Hoehn and Yahr PD severity classification.
4.6.3 Regression of UPDRS Motor Score
The severity groups are comprehensive measures of PD severity which include
many other factors which aren’t related to gait and motor dysfunction such as
mood, presence of hallucinations, fatigue, bladder control and so forth. For an
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examination of just the motor functions of PD, we consider only Part 3 of the UP-
DRS Score, the Motor Examination. It provides a finer-grain measure of the motor
dysfunction severity, with parameters which describe the presence and severity of
tremor, rigidity, hand movement, leg agility, freezing of gait and so forth. The
UPDRS motor score consists of a series of questions on a 4-5 point scale covering
various motor control aspects. The higher the total score, the more severe the
symptoms are. In our experiment, the UPDRS motor scores of all PD patients
range from 9 to 72, and a PD stage corresponds to a score range of approximately
20 points. Researchers have used sensors to estimate various sub-scores of the
motor score of PD patients, but not the total motor score [133]. In the follow-
ing sections, we aim to use machine learning regression techniques to predict the
UPDRS motor score of a PD patient.
4.6.4 Feature Extraction and Processing
We use the same set of features extracted from the body sensors to train both
severity classification and UPDRS score regression models. Many studies only use
the foot sensors or only walking data for these tasks. In our study, we aim to obtain
an accurate estimation of the subject severity by taking advantage of the multiple
motor symptom tests we conducted with multiple body sensors. Specifically, we
use four sensors on the limbs to estimate the PD severity: two sensors on the feet
to collect walking data, and two on the wrists to collect hand rotation data (see
Section 4.7).
To investigate the effectiveness of the sensor data from different body parts,
we extract and compare three different types of sensor features: hand sensor fea-
tures (for hand rotation tests), foot sensor features (for walking tests), and the
combination of the two. An example of the hand rotation data from the left
wrist of a subject can be seen in Figure 4.7. As shown in the figure, the rota-
tion rate waveforms display clear periodic patterns but with different amplitudes
and frequencies. The segmented hand rotation data from both wrists is used for
107


















X axis Y axis Z axis























Figure 4.7: Example accelerometer and gyroscope waveforms from one IMU during
hand rotation.
feature extraction. To extract the most information out of the data, we use both
time domain and frequency domain features. Time domain features focus on the
statistics regarding the waveforms, which are similar to the features described in
Section 4.5. A fast Fourier transform (FFT) is performed on each waveform to
obtain the power spectrum, from which various features are extracted, such as
(inspired by music frequency analysis e.g. [137]):
• Spectral centroid: the center of the magnitude distribution of the spectrum.
• Spectral rolloff: the frequency under which 95% (or 80%, etc.) of the power
distribution is concentrated.
• Spectral flux: a measure of short-time changes of the spectrum.
For each hand, the time domain and frequency domain features extracted
from all the waveforms are concatenated into a feature vector. The final feature
set for a subject is a combination of the feature vectors of both hands as well
as the difference between the two feature vectors, which indicates the asymmetry
between two hands.
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To extract the walking features for each subject, we first gather all the steps
and strides data for the subject, and then process the data separately for left
foot and right foot. The walking features consist of two main parts: gait statistic
features and raw sensor data features, which captures both high-level and lower-
level information about the walking patterns. Gait statistic features include the
statistics (mean, variation, range, etc.) of the collective gait parameters (stride
time/length, step time/length). Raw sensor data features utilize the features
extracted for each step as in the machine learning step length algorithm (see
Section 4.5), which involve the waveform features of the foot sensors. The mean
and standard deviation of the all the step features are calculated and concatenated
as a feature vector. Similarly, a feature vector is extracted from the stride data.
All these feature vectors are concatenated into one vector for each subject.
Similar machine learning procedures are performed to train a classifier based
on the Multi-Layer Perceptron (MLP), as described in Section 4.5. Feature stan-
dardization and PCA are conducted in the processing “pipeline”, and grid search
is used to find the best combination of the model parameters. Given six severity
groups, we use 6-fold cross-validation to reduce the effect of over-fitting.
4.7 Clinical Experiment Design
To test our new system, algorithms, technology and applications, we designed
and performed a clinical experiment at Huashan Hospital, Fudan University in
Shanghai, China.
4.7.1 Experiment Protocol
To simulate a rural hospital, we were provided with a basic and bare room with
only power outlets. Any technical equipment that is not part of MANA was
excluded from the experiment. We recruited forty PD patients, ten patients for
each severity group and ten RBD patients. Additionally, ten age and sex matched
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healthy subjects were recruited from the public as healthy controls. In total there
were sixty participants, separated into severity groups which are in increasing
order: HC, RBD, PD1, PD2, PD3, and PD4. Subjects could be included if they
met the following criteria:
• Between 50-75 years old.
• Capable of reading, understanding, and signing the informed consent (no
cognitive impairment).
• No serious internal diseases or other conditions which would effect their
ability to perform the tasks required.
• No gait abnormalities or symptoms caused by other disorders which could
affect analysis.
All testing procedures were approved by the Institutional Review Board (IRB)
at Huashan Hospital, and all subjects signed consent forms. All patients were
recruited from the Parkinson’s Database Study of Huashan Hospital. PD patients
were required to be in a medication deplete state to fully show their symptoms
during the trial.
Subjects were evaluated by neurologists on the day of the test to give an
evaluation of their disease stage. Data on subject condition, as well as other
important data such as height, weight, age and so forth were collected on each
subject. All of the experiment was filmed to serve as ground truth and also for
blind testers to evaluate the status of each patient.
Each subject was equipped with five sensors, two embedded in the shoes, two
on the wrists, and one on the waist (see Figure 4.4a), which recorded accelerometer
and gyroscope data at 100 Hz and then transmitted to the Collator app. The pa-
tients wore this equipment for the entirety of the mobility test (see Section 4.7.3),
to capture not only their walking but their upper body motor functions.
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The intention of this experiment was to test our system across a large and
diverse set of subjects with varying degrees of symptom severity. As a comparison
we test our system against ground truth measurements of stride length.
4.7.2 Ground Truth for Gait Length Measures
There are many commercial systems which could serve as ground truth for our
IMU-based gait length estimation method. GaitRITE is one of the more commonly
used systems. However, the unit price of GaitRITE is more than USD $72,000 in
China, which is far beyond the means of a rural hospital. Therefore we obtained
our ground truth measurement for stride length by using a custom computer vision
(CV) based system [164], which records videos during walking and extracts stride
length from the locations of the feet.
The system consists of a smartphone camera pointed at a printed polyvinyl
mat, with alternating black and white markers every ten cm which act as a ruler
and perspective guide for the camera. The system also uses colored shoes to
automatically differentiate between left and right feet. It extracts stride time and
stride length measurements and is time-synchronized to the other components
of MANA. The clinical experiment setup and walking example can be seen in
Figure 4.8 (a) and (b).
The total cost of this system was under USD $800, with most of the expense
being the smartphone itself, a component that will only become cheaper over
time. This system has a mean absolute error in estimating stride length of 0.62
cm, which is comparable to GAITRite, and is relatively small (0.6%) compared
to the mean stride length of 102 cm in our study (cf. Section ??). It should be
noted that this CV-based method could be replaced by any existing commercial
system such as GAITRite for the purpose of validation of our MANA system. As





Figure 4.8: (a.) Clinical experimental setup. (b.) A walking example. (c.) Walking
path (the red dotted line).
4.7.3 Test Procedure
The test procedure for mobility analysis involved two parts, a walking track (see
Figure 4.8c) and a motor symptoms test. Subjects were required to walk unas-
112
sisted approximately 8-10 times around this walking track continuously to give a
minimum of around 30 strides of each foot. The walking track has two turns, one
at the beginning and one at the end.
Next, subjects of the clinical experiment were required to perform a series of
motor tasks for the purposes of symptom evaluation. These tasks consist of right
and left foot stomping, unassisted stand up from sitting, an arm out steadiness
test, hand rotations, hand clasps, and finger pinching. These are common tests
neurologists and clinicians perform to evaluate motor control and are based on
the UPDRS test scoring. Using the data collected by MANA it is possible to
discriminate between the severity of each patients PD as well as evaluate their
gait parameters.
4.8 Experiments and Results
This section presents the experimental results of our proposed algorithms on the
clinical dataset, including the stride length, step length, and PD classification
algorithms.
4.8.1 Evaluation of Stride Length Algorithms
4.8.1.1 Baseline Stride Length Algorithms
We proposed two stride length (SL) algorithms based on kinematics (Section 4.4):
the Reset-based algorithm (SL-Reset) and the Optimization-based algorithm (SL-
Opt). Both algorithms take advantage of all 6 axes of IMU data for sensor fusion.
To compare with existing methods, two baseline algorithms are implemented.
The first baseline is a machine learning-based stride length algorithm (SL-ML),
which is based on the foot sensor and uses the same procedures as the step length
algorithm as described in Section 4.5.
Many other studies also use 3 axes of IMU data (aAP , aUD and ωLR) to calculate
113
Table 4.1: Measurement errors of four stride length estimation algorithms.
Algorithm Condition
Error: cm (percentage error: %)
Mean MAE SD
SL-Reset
Initial -3.78 (-3.09) 6.9 (5.71) 10.14 (7.8)
Subject-based 0.03 (0.02) 6.72 (5.68) 9.83 (7.7)
Non-subject-based 0 (0) 6.68 (5.61) 9.79 (7.32)
SL-Opt
Initial -2.16 (1.8) 5.78 (4.8) 7.83 (5.7)
Subject-based 0.02 (0.02) 5.72 (4.71) 7.84 (5.64)
Non-subject-based 0 (0) 5.7 (4.71) 7.81 (5.62)
SL-3axes
Initial -7.32 (6.14) 8.8 (7.35) 10.19 (7.28)
Subject-based 0.03 7.06 (5.87) 10 (7.22)
Non-subject-based 0 (0) 7.02 (5.86) 9.95 (7.3)
SL-ML
Subject-based 0.94 (0.78) 6.07 (5.28) 8.19 (5.85)
Non-subject-based 0.78 (0.65) 5.93 (5.02) 8.09 (5.78)
stride length in straight-line walking [142; 162], which is implemented here as
another baseline algorithm (SL-3axes). This baseline algorithm assumes that the
IMU movement during walking is restricted within the plane (PGUD,AP ) formed
by
#    –
UDG and
#    –
APG. The acceleration is projected to the
#    –
APG axis for double
integration. Similarly the linear resetting function h0(·) in Equation (4.11) and
the linear regression method as described in Section 4.4.4 are also applied.
4.8.1.2 Experimental results
A stride length dataset of 5176 strides from both feet was combined across 60
subjects, with a minimum of 30 strides for each subject. The ground-truth of the
stride length was obtained from the computer vision method (cf. Section 4.7.2).
Since the subjects vary from healthy controls to severe PD patients, the stride
length dataset has a large range from 29 cm to 159 cm. The mean and standard
deviation of the stride lengths are 102 cm and 24 cm, respectively.
Four stride length algorithms (SL-Reset, SL-Opt, SL-ML and SL-3axes) were
tested on this dataset and compared to ground truth measurements. Different
metrics have been used in the literature to quantify the measurement errors, and
here we report the mean error, mean absolute error (MAE), and the standard
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Figure 4.9: Measurement errors (MAE and SD) of four stride length estimation algo-
rithms.
deviation (SD) of the errors (in cm) for each algorithm, as shown in Table 4.1.
Figure 4.9 also shows the MAE and SD of the estimation errors. Furthermore,
since the stride length varies across a large range, we also calculate the normal-
ized percentage error, which is the estimation error divided by the ground-truth
stride length and multiplied by 100. Each row in the table represents a different
condition of the algorithm, where “Initial” means the original estimation of stride
length without applying the linear regression method (cf. Section 4.4.4), and
“Subject-based” and “Non-subject-based” mean linear regression is applied and
tested using cross-validation with subject-based and non-subject-based splitting
methods, respectively.
As can be seen from the table, both SL-Reset and SL-Opt outperform the
baseline algorithm SL-3axes. SL-Opt has the smallest errors across all error met-
rics, with a mean absolute error of approximately 5.7 cm (or 4.7%). This indicates
the effectiveness of the constraint-based optimization approach. SL-Reset also has
relatively small errors, but is slightly larger than SL-ML. This indicates that SL-
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Table 4.2: Measurement errors of two step length estimation algorithms.
Algorithm Condition
Error: cm (percentage error: %)
Mean MAE SD
StepL-W
Subject-based 0.69 (1.21) 5.42 (8.9) 7.13 (11.8)
Non-subject-based 0.48 (0.9) 5.31 (8.63) 7.08 (11.2)
StepL-WF
Subject-based 0.7 (1.2) 4.14 (7.1) 5.49 (9.03)
Non-subject-based 0.66 (1.17) 3.86 (6.53) 5.19 (8.54)
Reset can mitigate the integration drift problem, although its modeling capability
and adaptability are not as good as SL-Opt.
These errors of the proposed SL-Reset and SL-Opt algorithms are smaller than
other 6-axes IMU-based studies that are tested on PD subjects, for example a mean
error of 8.5 (± 5.5) cm [30]. It is worth noting that our study involves a large
group of subjects with a wide range of gait styles and stride lengths. Therefore,
comparing our proposed methods with the baseline methods on the same dataset is
more straightforward than comparing with results from other datasets as reported
in other studies.
By applying linear regression, the errors of all algorithms are reduced, where
the mean error is reduced the most (to almost zero) while the SD of the error
stays almost the same. Note that subject-based and non-subject-based splitting
methods yield similar results, which implies good generalizability of the method
to new subjects. A mean error of about zero indicates an accurate algorithm
for estimating the total walking distance (such as in pedestrian tracking), and
outperforms existing studies.
4.8.2 Evaluation of Step Length Algorithms
A step length dataset of 4831 steps was combined across 60 subjects, with the
ground-truth step length obtained from the computer vision method (cf. Sec-
tion 4.7.2). The size of the step length dataset is slightly smaller than the stride
length dataset because each step requires the existence of two strides of both feet
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and the missing of the ground-truth of one stride (e.g., the stride at the end of
a walking session is outside of the camera range) can render the step unusable.
The step length dataset ranges from 12 cm to 82 cm, with a mean of 51 cm and
standard deviation 12 cm.
Two machine learning-based step length algorithms were proposed in Sec-
tion 4.5, with one algorithm (StepL-W) using the waist sensor only and the other
(StepL-WF) using both waist and foot sensors. Similarly, both subject-based
and non-subject-based splitting methods are tested in the cross-validation of the
two algorithms, with the measurement errors shown in Table 4.2. By incorporat-
ing the information from the foot sensor, StepL-WF (e.g., MAE = 4.14 cm) has
smaller errors than StepL-W (e.g., MAE = 5.41 cm), and its accuracy is com-
parable to other studies [163]. The similar performance of both subject-based
and non-subject-based splitting methods indicate good generalizability for both
algorithms.
By measuring stride and step length for both feet, MANA can provide com-
prehensive insights of the spatial gait dynamics, as well as the statistics (e.g.,
variation) and comparison between two feet, which is a fundamental part of clin-
ical gait and mobility analysis.
4.8.3 Evaluation of PD Severity Classification and UPDRS Re-
gression
In our clinical study, 49 subjects have both walking data and hand rotation data.
The PD classification methods (cf. Section 4.6) were tested on these 49 subjects
from all 6 severity groups: HC, RBD, PD1, PD2, PD3 and PD4. In Table 4.3
for the binary split classification scheme, it is possible to see that any choice of
threshold group has a high classification accuracy (87% to 100%). As expected, the
combining of foot and hand features performs better than each separately, with the
accuracy ranging from 98% to 100%. This suggests that for diagnosis (binary clas-
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sification), MANA is able to distinguish between those with PD and those with-
out. This is useful for early diagnosis of PD. The classification accuracy is higher
than other studies which separate patients based on two severity groups [140;
23].
In the multi-class scheme (see Table 4.4), it shows that separating the subjects
into PD severity groups can be performed with 90% accuracy. Classifiers trained
on foot features outperformed those trained on hand features, which may be due to
the volume of the gait data collected per subject being larger than hand rotation
data. In addition, tremor is usually not very prominent in the hand rotation test
and is hard to capture. In future research, we can design tests to capture tremor
more effectively.
The UPDRS motor score regression was tested on 30 PD patients across four
PD groups. HC and RBD groups were not scored using UPDRS as it is specifically
targeted at PD patients. The UPDRS regression result (see Table 4.4) shows that
the system can estimate the UPDRS motor score to within 5 points (14% range of
ground-truth score) using combined foot and hand features. This regression error
is relatively small compared to the range of about 20 points that a PD severity
stage spans. By contrast, the hand features have a large mean absolute error (8.3)
but this is likely due to more of the UPDRS motor score diagnostic criteria being
related to gait than hand movement.
These results strongly suggest MANA could be used as the basis for diagnosis
and severity classification of PD. It could also serve to help clinicians confirm
or double check the UPDRS motor score of a patient. Including more features
(as captured by the sensors) will likely improve UPDRS motor score estimation
accuracy.
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Table 4.3: PD severity groups binary split and classification accuracy.
Group split scheme Classification accuracy (%)
Less severe groups More severe groups Hand Foot Combined
HC RBD, PD1, PD2, PD3,
PD4
97.50 100.00 100.00
HC, RBD PD1, PD2, PD3, PD4 98.33 98.57 98.33
HC, RBD, PD1 PD2, PD3, PD4 87.00 93.00 95.50
HC, RBD, PD1, PD2 PD3, PD4 98.00 98.33 98.00
HC, RBD, PD1, PD2,
PD3
PD4 100.00 100.00 100.00


















4.9 Discussion and Conclusions
In this chapter we proposed an all-in-one cyber-physical system for mobility anal-
ysis, including a body sensor network (two sensors embedded in the shoes, two on
the wrists, and one on the waist) and a data analysis and visualization backend.
We introduced novel and accurate gait analysis algorithms by fusing accelerom-
eter and gyroscope data and utilizing imposed kinematic constraints. We built
a classifier based on the sensor data to classify subjects into six clinical severity
groups with 90% accuracy outperforming other PD classifiers. A binary classifier
is also used to split the subjects into two severity groups (98%-100% accuracy),
and prediction of the UPDRS motor score is performed using regression with a
mean absolute error of 5 points. We also performed a clinical trial on 60 PD
patients and elderly subjects to validate our system and algorithms.
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Embedding the sensor in the shoe enabled the development of novel algorithms
for gait length estimation. This is an important differentiating characteristic of our
system in contrast to most commercial systems which use ankle mounted sensors.
This new location is shown to be an advantage for some stride length estimation
algorithms (specifically for justifying zero point assumptions). Furthermore, the
unobtrusiveness of the sensor location makes long term monitoring using MANA
a strong possibility.
Another advantage of our system is the sensor fusion. For example, our ex-
periments have shown that step length estimation using waist and foot sensors
outperforms systems which only use waist sensors alone. In addition, the PD
severity classification and UPDRS regression results are more accurate by com-
bining hand and foot sensor features. In the future, combining all five sensors
could lead to improvements in gait parameter estimation algorithms. Currently
our algorithms only consider straight line walking, but they have the potential
to analyze non-straight line walking. The nature of gait abnormality in PD pa-
tients makes step length and stride length estimation challenging, and this poses
difficulty for gait variability measures which require extremely precise gait mea-
surement algorithms. This study did not take into account the turning walking
data available for each patient, nor the other symptom data collected. The au-
thors believe this will further improve classification accuracy. Although this is one
of largest studies of its type, sixty subjects is still relatively small, and we intend
to expand our dataset to include more subjects and symptom data.
The flexibility, portability, and scalability of MANA enables a wide range of
applications and use cases with high medical and social impact. Firstly, MANA
provides rural hospitals with access to gait analysis technology and specialist ex-
pertise normally only available at larger and better equipped hospitals. This can
facilitate PD diagnosis and severity classification, making earlier treatment inter-
ventions an option for rural patients, which will in turn lead to better patient
outcomes. MANA can also benefit patients as it is a convenient wearable system
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that patients can use in their own homes. This makes it possible to track the
motor performance of a patient over a much longer time period, providing more
accurate and fine grain information of disease state to specialists. This could help
in the design of more personalized and individualized treatment plans for patients.
Since MANA sensor data is uploaded to the hub rather than stored locally, it’s
easy to collect and store a large amount of data across a wide population anywhere
around the globe. This will allow us to perform data mining on the resultant big
data collected by the system and provide overall trends and inference to medical
specialists and public policy makers.
It is also worth noting that MANA is not only restricted to PD patient moni-
toring, but can also be used for mobility impairment evaluation in general, which
is common in the diagnosis and evaluation of many neurological conditions such as
stroke and Alzheimer’s disease. Furthermore, MANA lays out the technical foun-
dation for higher level applications to be developed and deployed. For example,
MANA could implement fall detection algorithms and then alert the appropriate
caregivers or emergency services. It could also detect other parkinsonian symp-
toms such as freezing of gait and perhaps provide audio or visual cues to help the
patient resume walking. Finally, it is possible to integrate or connect MANA to
other services, such as real-time personalized music recommendation engines (per-
haps based on gait cadence for rehabilitation), or fitness tracking applications. In
conclusion, MANA represents a promising platform for accessible clinical mobility
analysis with a wide range of potential applications.
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Chapter 5
Conclusion and Future Work
5.1 Conclusion
As the burden of movement disorders such as PD continues to expand, accurate
and scalable tools for mobility analysis and disease assessment are greatly needed.
In this thesis, we investigate inertial sensor-based mobility analysis algorithms and
systems for PD. We developed and validated two systems: a smartphone-based
mobile application (iRACE) and a wearable system using custom-built inertial
sensors (MANA).
Chapter 3 describes the iRACE mobile app. iRACE uses a smartphone to as-
sess motor performance and deliver customized Rhythmic Auditory Cueing (RAC)
to facilitate gait training. The smartphone’s built-in inertial sensors are used to
assess step time and step length during walking, and the touchscreen is used to
assess motor timing during index finger tapping. Novel machine learning-based
gait analysis algorithms have been developed for iRACE, including heel strike de-
tection, step length quantification, and left-versus-right foot identification. The
concurrent validity of iRACE was assessed using an instrumented walking mat
and a pair of pressure sensors. This presents the first ever systematic ground
truth validation of the accuracy of smartphone-based gait analysis in PD. Results
from 12 PD patients and 12 age-matched healthy elderly reveal that iRACE has
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low error rates across a set of four clinically relevant outcome measures for motor
performances with and without RAC, indicating a potentially useful clinical tool.
Chapter 4 describes the MANA system. MANA is an cost-effective, accurate,
wearable and scalable system based on custom inertial sensors. MANA uses five
sensors (two embedded in the shoes, two on the wrists, and one on the waist) for
motion tracking, and uses a companion mobile app and web service for data col-
lection and visualization. We performed a clinical trial on sixty subjects equally
split into six severity groups (forty with various stages of PD). Each subject was
equipped with five sensors and was instructed to perform a walking test and a
motor control test. Comprehensive temporal and spatial gait analyses were per-
formed based on the sensor data. Novel stride length algorithms were developed
based on sensor fusion and kinematic constraints, which outperformed existing
methods. Furthermore, we were able to classify subjects into six severity groups
with 90% accuracy. A binary classifier is also used to split the subjects into two
severity groups (98%-100% accuracy), and prediction of the UPDRS motor score
is performed using regression with a small error. Experiments showed that MANA
is a promising platform for clinical gait and mobility analysis.
A major technical difference between iRACE and MANA is the inertial sensors
they use. As iRACE uses the built-in sensors of a smartphone, it does not require
the subject to wear extra inertial sensors. This leads to both advantages and
disadvantages for iRACE. On the one hand, iRACE only requires one device (a
smartphone) to be attached to the waist, which is easier to set up and maintain.
This is helpful for patients with severe mobility impairment. On the other hand,
MANA uses five sensors on the limbs and waist, and can measure more movements
of the body with higher accuracy. As a smartphone is much larger and heavier
than a standalone inertial sensor, it is not practical to mount a smartphone on
the wrist or foot.
As iRACE runs on a smartphone, it can also assess finger tapping and deliver
Rhythmic Auditory Cueing (RAC) for gait training. These functions are currently
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not available in the MANA mobile app (the Collator), but they can definitely be
integrated into the Collator app, thus providing more powerful services in one app.
iRACE was first developed on the iOS platform, which has higher screen refresh
rate and better access to built-in sensors than most Android phones at the time of
development (in 2012). The Collator was first developed on the Android platform
due to its powerful and flexible Bluetooth API. However, with the continuous im-
provement of the smartphone hardware, there should be no problem to implement
the iRACE app and Collator app on all major mobile platforms, including iOS
and Android.
Both iRACE and MANA are inexpensive, flexible, portable, and scalable,
which enables a wide range of applications and use cases with high medical and
social impact. For example, they can provide rural hospitals with access to gait
analysis technology that is not available before, and thus facilitate PD diagnosis
and early interventions. In addition, iRACE and MANA can also benefit patients
as a convenient wearable system that patients can use in their own homes, enabling
long term monitoring and more accurate assessment of the disease. Furthermore,
since the sensor data collected by iRACE or MANA is uploaded to the cloud
server, it’s easy to collect and store a large amount of data across a wide popu-
lation anywhere around the globe. This will enable data mining on the resultant
big data, and provide personalized treatment (i.e., precision medicine) as well as
overall trends and inference to medical specialists and public policy makers.
The principle of iRACE and MANA is similar, which consists of two main
steps: motion analysis based on inertial sensors (e.g., step length measurement),
and disease assessment based on the motor performance (e.g., PD severity clas-
sification). Therefore, iRACE and MANA are not only restricted to PD patient
monitoring, but can also be used for mobility impairment evaluation in general,
which is common in the diagnosis and assessment of many neurological conditions
such as stroke and Alzheimer’s disease. In addition, they lay out the technical
foundation for higher level applications to be developed and deployed, such as
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detecting falls and freezing of gait. Finally, it is possible to integrate or connect
them to other services, such as real-time personalized music recommendation en-
gines. In conclusion, iRACE and MANA represent a promising mobile platform
for accessible clinical mobility analysis with a wide range of potential applications
in PD and beyond.
5.2 Future Work
Based on the work in this thesis, the following are some possible directions for
future research work.
From the technology perspective, there is still room to improve the accuracy
and scale of the motion measurements based on inertial sensors. By investigating
the sensor hardware design, sensor placement location and method, together with
data analysis algorithms, we can strike a balance between the sensor wearability
and measurement accuracy. Furthermore, new algorithms can be developed to
measure more parameters, such as the height of the foot lifted above ground
during walking, and the width (distance in the sideways direction) between two
feet. Additionally, the 3D trajectory of foot movement can be estimated, which
can be further analyzed to provide more information about mobility. To evaluate
the accuracy of a new algorithm or system, a carefully designed clinical trial with a
large sample size is necessary, although it may require more time and resources to
conduct. In turn, once a large dataset is collected, data mining can be performed
to discover new patterns in the data and thus improve the measurement accuracy.
Another direction is to monitor daily activities, including turns and walking
up and down stairs. Currently, most studies focus on straight-line walking on a
level ground, which is not always the case in the daily life. Besides, the patterns
in other daily activities may contain important information about the real status
of a subject. However, there are also challenges in the analysis of data collected
in the home and community settings, as the motion sensors do not always provide
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sufficient information for reliable assessment of motor symptoms. For instance, it
is difficult to infer from the sensor data alone if the detected slowness of movement
is the symptom of bradykinesia, or is the result of fatigue or other factors related
to the environment. Therefore, more sophisticated algorithms or the combination
of other types of sensors may be needed. Furthermore, it would be a worthwhile
effort to integrate different technologies to monitor both motor and non-motor
symptoms, such as depression, anxiety, and fatigue.
From the system perspective, the functionality and usability of the hardware
and software can be further enhanced. Firstly, great efforts are needed to im-
prove the user experience and user engagement of the system, as the usability is
particularly important for clinical systems targeting elderly users or people with
mobility impairment. For example, wireless charging of the sensor battery is an
important feature to improve the user experience. Indeed, a recent study showed
a high dropout rate among users of wearable devices and mobile apps [89]. One
strategy to encourage user engagement is to provide feedback and interact with
users. In addition, more advanced functions can be integrated into a motion track-
ing system. For example, fall detection algorithms can be implement to alert the
appropriate caregivers or emergency services. It could also detect other symptoms
such as freezing of gait, and perhaps provide audio or visual cues to help the pa-
tient resume walking. Finally, it is possible to connect a motion tracking system
to other services, such as real-time personalized music recommendation engines
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